Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Schizophr Res

Retrieve available abstracts of 692 articles:
HTML format
Text format



Single Articles


    August 2017
  1. COOPER PS, Hughes ME
    Impaired theta and alpha oscillations underlying stopsignal response inhibition deficits in schizophrenia.
    Schizophr Res. 2017 Aug 7. pii: S0920-9964(17)30469.
    PubMed     Text format    


  2. JOE P, Getz M, Redman S, Kranz TM, et al
    Transglutaminase-5 related schizophrenia.
    Schizophr Res. 2017 Aug 7. pii: S0920-9964(17)30470.
    PubMed     Text format    


  3. KOUTSOUKOS E, Angelopoulos E
    Investigating the role of metastability in the disturbed brain functional connectivity observed under the experience of thought blocks in schizophrenia.
    Schizophr Res. 2017 Aug 5. pii: S0920-9964(17)30466.
    PubMed     Text format    


  4. STRAUSS GP, Chapman HC
    Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30462.
    PubMed     Text format     Abstract available


  5. MCCARTHY JM, Bradshaw KR, Catalano LT, Garcia CP, et al
    Negative symptoms and the formation of social affiliative bonds in schizophrenia.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30445.
    PubMed     Text format     Abstract available


  6. LEE M, Sehatpour P, Dias EC, Silipo GS, et al
    A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30443.
    PubMed     Text format     Abstract available


  7. SRIHARI VH
    Working toward changing the Duration of Untreated Psychosis (DUP).
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30456.
    PubMed     Text format    


  8. MURALIDHARAN A, Finch A, Bowie CR, Harvey PD, et al
    Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia.
    Schizophr Res. 2017 Aug 1. pii: S0920-9964(17)30418.
    PubMed     Text format     Abstract available


    July 2017
  9. HOOPER SR, Shashi V
    Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30451.
    PubMed     Text format    


  10. EACK SM
    Promoting long-term functional improvement after cognitive remediation in schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30454.
    PubMed     Text format    


  11. FEATHERSTONE RE, Melnychenko O, Siegel SJ
    Mismatch negativity in preclinical models of schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30450.
    PubMed     Text format     Abstract available


  12. BRAEUTIGAM S, Dima D, Frangou S, James A, et al
    Dissociable auditory mismatch response and connectivity patterns in adolescents with schizophrenia and adolescents with bipolar disorder with psychosis: A magnetoencephalography study.
    Schizophr Res. 2017 Jul 28. pii: S0920-9964(17)30459.
    PubMed     Text format     Abstract available


  13. LALLY J, Ajnakina O, Stubbs B, Williams HR, et al
    Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.
    Schizophr Res. 2017 Jul 27. pii: S0920-9964(17)30448.
    PubMed     Text format     Abstract available


  14. ADAMS SA, Nasrallah HA
    Multiple retinal anomalies in schizophrenia.
    Schizophr Res. 2017 Jul 26. pii: S0920-9964(17)30419.
    PubMed     Text format     Abstract available


  15. AJNAKINA O, Lally J, Di Forti M, Stilo SA, et al
    Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30453.
    PubMed     Text format     Abstract available


  16. GILLESPIE SM, Abu-Akel AM
    Evidence for benefits in comorbid psychopathy and schizophrenia.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30457.
    PubMed     Text format    


  17. CHIU PW, Lui SSY, Hung KSY, Chan RCK, et al
    In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Schizophr Res. 2017 Jul 24. pii: S0920-9964(17)30422.
    PubMed     Text format     Abstract available


  18. WANG HY, Guo WJ, Li XJ, Tao YJ, et al
    Higher required dosage of antipsychotics to relieve the symptoms of first-onset Acute and Transient Psychotic Disorder (ATPD) predicted the subsequent diagnostic transition to schizophrenia: A longitudinal study.
    Schizophr Res. 2017 Jul 21. pii: S0920-9964(17)30412.
    PubMed     Text format    


  19. EBISCH SJH, Gallese V, Salone A, Martinotti G, et al
    Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30421.
    PubMed     Text format     Abstract available


  20. GANELLA EP, Seguin C, Bartholomeusz CF, Whittle S, et al
    Risk and resilience brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30415.
    PubMed     Text format     Abstract available


  21. FUSAR-POLI P, Palombini E, Davies C, Oliver D, et al
    Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30353.
    PubMed     Text format     Abstract available


  22. PILLAI A, Schooler NR, Peter D, Looney SW, et al
    Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30398.
    PubMed     Text format     Abstract available


  23. MORITZ S, Bentall RP, Kolbeck K, Roesch-Ely D, et al
    Monocausal attribution and its relationship with reasoning biases in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30396.
    PubMed     Text format     Abstract available


  24. FARGOTSTEIN M, Hasenkamp W, Gross R, Cuthbert B, et al
    The effect of antipsychotic medications on acoustic startle latency in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30432.
    PubMed     Text format     Abstract available


  25. ZULIANI R, Delvecchio G, Bonivento C, Cattarinussi G, et al
    Increased gyrification in schizophrenia and non affective first episode of psychosis.
    Schizophr Res. 2017 Jul 17. pii: S0920-9964(17)30399.
    PubMed     Text format     Abstract available


  26. LU ML, Chen CH, Kuo PT, Lin CH, et al
    Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia.
    Schizophr Res. 2017 Jul 15. pii: S0920-9964(17)30423.
    PubMed     Text format     Abstract available


  27. O'REILLY K, O'Connell P, Corvin A, O'Sullivan D, et al
    Moral cognition and homicide amongst forensic patients with schizophrenia and schizoaffective disorder: A cross-sectional cohort study.
    Schizophr Res. 2017 Jul 14. pii: S0920-9964(17)30428.
    PubMed     Text format     Abstract available


  28. GAWEDA L, Prochwicz K, Adamczyk P, Frydecka D, et al
    The role of self-disturbances and cognitive biases in the relationship between traumatic life events and psychosis proneness in a non-clinical sample.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30424.
    PubMed     Text format     Abstract available


  29. HORAN WP, Green MF
    Treatment of social cognition in schizophrenia: Current status and future directions.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30414.
    PubMed     Text format     Abstract available


  30. REKHI G, Ng WY, Lee J
    Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30395.
    PubMed     Text format     Abstract available


  31. COMPARELLI A, Corigliano V, Lamis DA, De Carolis A, et al
    Positive symptoms and social cognition impairment affect severity of suicidal ideation in schizophrenia.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30427.
    PubMed     Text format    


  32. HATTORI S, Kishida I, Suda A, Miyauchi M, et al
    Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30405.
    PubMed     Text format     Abstract available


  33. LINDGREN M, Torniainen-Holm M, Harkanen T, Dickerson F, et al
    The association between toxoplasma and the psychosis continuum in a general population setting.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30391.
    PubMed     Text format     Abstract available


  34. RETSA C, Knebel JF, Geiser E, Ferrari C, et al
    Treatment in early psychosis with N-acetyl-cysteine for 6months improves low-level auditory processing: Pilot study.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30409.
    PubMed     Text format     Abstract available


  35. VERAS AB, Peixoto C, Messinger JW, Getz M, et al
    Early trauma and clinical features of schizophrenia cases influenced by the BDNF met allele.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30400.
    PubMed     Text format    


  36. HAMILTON HK, D'Souza DC, Ford JM, Roach BJ, et al
    Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30379.
    PubMed     Text format     Abstract available


  37. HOLMEN TL, Egeland J, Andersen E, Bigseth TT, et al
    The association between cardio-respiratory fitness and cognition in schizophrenia.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30416.
    PubMed     Text format     Abstract available


  38. BONFIOLI E, Mazzi MA, Berti L, Burti L, et al
    Physical health promotion in patients with functional psychoses receiving community psychiatric services: Results of the PHYSICO-DSM-VR study.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30356.
    PubMed     Text format     Abstract available


  39. DUTSCHKE LL, Stegmayer K, Ramseyer F, Bohlhalter S, et al
    Gesture impairments in schizophrenia are linked to increased movement and prolonged motor planning and execution.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30413.
    PubMed     Text format     Abstract available


  40. AVISSAR M, Xie S, Vail B, Lopez-Calderon J, et al
    Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30410.
    PubMed     Text format     Abstract available


  41. KOOLA MM, Sklar J, Davis W, Nikiforuk A, et al
    Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
    Schizophr Res. 2017 Jul 10. pii: S0920-9964(17)30406.
    PubMed     Text format    


  42. KONRADI C, Ongur D
    Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders.
    Schizophr Res. 2017 Jul 10. pii: S0920-9964(17)30408.
    PubMed     Text format    


  43. GARDSJORD ES, Romm KL, Rossberg JI, Friis S, et al
    Is going into stable symptomatic remission associated with a more positive development of life satisfaction? A 10-year follow-up study of first episode psychosis.
    Schizophr Res. 2017 Jul 9. pii: S0920-9964(17)30407.
    PubMed     Text format     Abstract available


  44. BRUNETTE MF, Mueser KT, Babbin S, Meyer-Kalos P, et al
    Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Schizophr Res. 2017 Jul 8. pii: S0920-9964(17)30378.
    PubMed     Text format     Abstract available


  45. XAVIER RM, Pan W, Dungan JR, Keefe RSE, et al
    Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
    Schizophr Res. 2017 Jul 7. pii: S0920-9964(17)30403.
    PubMed     Text format     Abstract available


  46. BERRY C, Greenwood K
    Direct and indirect associations between dysfunctional attitudes, self-stigma, hopefulness and social inclusion in young people experiencing psychosis.
    Schizophr Res. 2017 Jul 7. pii: S0920-9964(17)30377.
    PubMed     Text format     Abstract available


  47. SUBRAMANIAM K, Gill J, Fisher M, Mukherjee P, et al
    White matter microstructure predicts cognitive training-induced improvements in attention and executive functioning in schizophrenia.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30401.
    PubMed     Text format     Abstract available


  48. RAMYEAD A, Kometer M, Studerus E, Andreou C, et al
    Abnormal brain connectivity during error-monitoring in the psychosis high-risk state.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30394.
    PubMed     Text format    


  49. SEDGWICK O, Young S, Greer B, Arnold J, et al
    Sensorimotor gating characteristics of violent men with comorbid psychosis and dissocial personality disorder: Relationship with antisocial traits and psychosocial deprivation.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30384.
    PubMed     Text format     Abstract available


  50. KIRKPATRICK B, Kennedy BK
    Accelerated aging in schizophrenia and related disorders: Future research.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30373.
    PubMed     Text format     Abstract available


  51. LU ML, Chen TT, Kuo PH, Hsu CC, et al
    Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study.
    Schizophr Res. 2017 Jul 5. pii: S0920-9964(17)30368.
    PubMed     Text format     Abstract available


  52. WHITFORD V, O'Driscoll GA, Titone D
    Reading deficits in schizophrenia and their relationship to developmental dyslexia: A review.
    Schizophr Res. 2017 Jul 5. pii: S0920-9964(17)30388.
    PubMed     Text format     Abstract available


  53. DONG D, Wang Y, Chang X, Chen X, et al
    Common and diagnosis-specific fractional anisotropy of white matter in schizophrenia, bipolar disorder, and major depressive disorder: Evidence from comparative voxel-based meta-analysis.
    Schizophr Res. 2017 Jul 4. pii: S0920-9964(17)30404.
    PubMed     Text format    


  54. LUCK M, Turner M, Shad MU
    Effectiveness of genetically-guided treatment in first-episode schizophrenia.
    Schizophr Res. 2017 Jul 2. pii: S0920-9964(17)30390.
    PubMed     Text format    


  55. COHEN CI, Murante T
    A prospective analysis of the role of cognition in three models of aging and schizophrenia.
    Schizophr Res. 2017 Jul 2. pii: S0920-9964(17)30361.
    PubMed     Text format     Abstract available


  56. MORAR B, Badcock JC, Phillips M, Almeida OP, et al
    The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia.
    Schizophr Res. 2017 Jul 1. pii: S0920-9964(17)30393.
    PubMed     Text format     Abstract available


    June 2017
  57. JANSSENS S, Moens H, Coppens V, Vandendriessche F, et al
    Psychomotor assessment as a tool to differentiate schizophrenia from other psychotic disorders.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30386.
    PubMed     Text format     Abstract available


  58. BISMARK AW, Thomas ML, Tarasenko M, Shiluk AL, et al
    Relationship between effortful motivation and neurocognition in schizophrenia.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30381.
    PubMed     Text format     Abstract available


  59. MAK M, Misiak B, Frydecka D, Pelka-Wysiecka J, et al
    Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophrenia.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30389.
    PubMed     Text format     Abstract available


  60. SVERAK T, Albrechtova L, Lamos M, Rektorova I, et al
    Intensive repetitive transcranial magnetic stimulation changes EEG microstates in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30383.
    PubMed     Text format    


  61. BUCHY L, Makowski C, Malla A, Joober R, et al
    A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis.
    Schizophr Res. 2017 Jun 29. pii: S0920-9964(17)30387.
    PubMed     Text format     Abstract available


  62. MAZIADE M, Paccalet T, Gilbert E
    Defective compensation over early dysneurogenesis in schizophrenia and mood disorder.
    Schizophr Res. 2017 Jun 27. pii: S0920-9964(17)30380.
    PubMed     Text format    


  63. JAVITT DC, Lee M, Kantrowitz JT, Martinez A, et al
    Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Schizophr Res. 2017 Jun 27. pii: S0920-9964(17)30362.
    PubMed     Text format     Abstract available


  64. MISDRAHI D, Tessier A, Husky M, Lange AC, et al
    Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS(R)): A six-month post-discharge prospective study.
    Schizophr Res. 2017 Jun 26. pii: S0920-9964(17)30365.
    PubMed     Text format     Abstract available


  65. BIOQUE M, Garcia-Portilla MAP, Garcia-Rizo C, Cabrera B, et al
    Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.
    Schizophr Res. 2017 Jun 26. pii: S0920-9964(17)30370.
    PubMed     Text format     Abstract available


  66. VILLA J, Choi J, Kangas JL, Kaufmann CN, et al
    Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia.
    Schizophr Res. 2017 Jun 24. pii: S0920-9964(17)30351.
    PubMed     Text format     Abstract available


  67. LIANG S, Brown MRG, Deng W, Wang Q, et al
    Convergence and divergence of neurocognitive patterns in schizophrenia and depression.
    Schizophr Res. 2017 Jun 23. pii: S0920-9964(17)30332.
    PubMed     Text format     Abstract available


  68. DAI J, Du X, Yin G, Zhang Y, et al
    Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naive patients with schizophrenia presenting with first episode psychosis.
    Schizophr Res. 2017 Jun 23. pii: S0920-9964(17)30369.
    PubMed     Text format     Abstract available


  69. DAVIDSON CA, Lesser R, Parente LT, Fiszdon JM, et al
    Psychometrics of social cognitive measures for psychosis treatment research.
    Schizophr Res. 2017 Jun 22. pii: S0920-9964(17)30357.
    PubMed     Text format     Abstract available


  70. HORN M, D'Hondt F, Gharib A, Gangloff L, et al
    Association between familiarity disorders and serious violence among inmates with schizophrenia.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30371.
    PubMed     Text format    


  71. SUN Z, Ma Y, Li W, He J, et al
    Associations between the DBH gene, plasma dopamine beta-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30367.
    PubMed     Text format     Abstract available


  72. MEHTA UM, Ravishankar V, Thirthalli J
    Eszopiclone for persistent negative symptoms in schizophrenia - An unintended N-of-1 study.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30374.
    PubMed     Text format     Abstract available


  73. UHL I, Kulik A, Roser P, Theodoridou A, et al
    Central serotonergic function in patients with predominantly negative symptoms of schizophrenia.
    Schizophr Res. 2017 Jun 19. pii: S0920-9964(17)30327.
    PubMed     Text format    


  74. FRIES GR, Dimitrov DH, Lee S, Braida N, et al
    Genome-wide expression in veterans with schizophrenia further validates the immune hypothesis for schizophrenia.
    Schizophr Res. 2017 Jun 19. pii: S0920-9964(17)30355.
    PubMed     Text format     Abstract available


  75. STUBBS B, Vancampfort D, Firth J, Hallgren M, et al
    Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries.
    Schizophr Res. 2017 Jun 18. pii: S0920-9964(17)30364.
    PubMed     Text format     Abstract available


  76. BORA E, Yalincetin B, Akdede BB, Alptekin K, et al
    Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis.
    Schizophr Res. 2017 Jun 17. pii: S0920-9964(17)30360.
    PubMed     Text format     Abstract available


  77. KOH MT, Shao Y, Rosenzweig-Lipson S, Gallagher M, et al
    Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.
    Schizophr Res. 2017 Jun 17. pii: S0920-9964(17)30366.
    PubMed     Text format     Abstract available


  78. MILLMAN ZB, Pitts SC, Thompson E, Kline ER, et al
    Perceived social stress and symptom severity among help-seeking adolescents with versus without clinical high-risk for psychosis.
    Schizophr Res. 2017 Jun 16. pii: S0920-9964(17)30330.
    PubMed     Text format     Abstract available


  79. HSU CW, Lee SY, Wang LJ
    Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
    Schizophr Res. 2017 Jun 16. pii: S0920-9964(17)30359.
    PubMed     Text format     Abstract available


  80. ZHANG T, Guo X, Tang Y, Cui H, et al
    Time consumption in mind-reading: A potentially important factor for social cognition assessment in early psychosis.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30354.
    PubMed     Text format    


  81. BENDELS MHK, Bauer J, Schoffel N, Groneberg DA, et al
    The gender gap in schizophrenia research.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30358.
    PubMed     Text format    


  82. LEE TY, Lee J, Kim M, Kwon JS, et al
    The effect of transcranial direct current stimulation on auditory hallucination in patients with schizophrenia.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30352.
    PubMed     Text format    


  83. AN H, Zhou L, Yu Y, Fan H, et al
    Serum NCAM levels and cognitive deficits in first episode schizophrenia patients versus health controls.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30348.
    PubMed     Text format     Abstract available


  84. SIMOILA L, Isometsa E, Gissler M, Suvisaari J, et al
    Schizophrenia and induced abortions: A national register-based follow-up study among Finnish women born between 1965-1980 with schizophrenia or schizoaffective disorder.
    Schizophr Res. 2017 Jun 11. pii: S0920-9964(17)30313.
    PubMed     Text format     Abstract available


  85. APPIANI FJ, Castro GS
    Catatonia is not schizophrenia and it is treatable.
    Schizophr Res. 2017 Jun 10. pii: S0920-9964(17)30305.
    PubMed     Text format     Abstract available


  86. KELLER-VARADY K, Varady PA, Roh A, Schmitt A, et al
    A systematic review of trials investigating strength training in schizophrenia spectrum disorders.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30336.
    PubMed     Text format     Abstract available


  87. LANGBEIN K, Schmidt U, Schack S, Biesel NJ, et al
    State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30335.
    PubMed     Text format     Abstract available


  88. GREENWOOD LM, Leung S, Michie PT, Green A, et al
    The effects of glycine on auditory mismatch negativity in schizophrenia.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30306.
    PubMed     Text format     Abstract available


  89. BHAVSAR V, Fusar-Poli P, McGuire P
    Neighbourhood deprivation is positively associated with detection of the ultra-high risk (UHR) state for psychosis in South East London.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30334.
    PubMed     Text format     Abstract available


  90. WEI Y, Collin G, Mandl RCW, Cahn W, et al
    Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30304.
    PubMed     Text format     Abstract available


  91. MOLINA V, Alvarez-Astorga A, Lubeiro A, Ortega D, et al
    Early neglect associated to prefrontal structural disconnectivity in schizophrenia.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30333.
    PubMed     Text format    


  92. ORBAN P, Dansereau C, Desbois L, Mongeau-Perusse V, et al
    Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivity.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30302.
    PubMed     Text format     Abstract available


  93. GAWEDA L, Prochwicz K, Krezolek M, Klosowska J, et al
    Self-reported cognitive distortions in the psychosis continuum: A Polish 18-item version of the Davos Assessment of Cognitive Biases Scale (DACOBS-18).
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30328.
    PubMed     Text format     Abstract available


  94. LYNN STARR H, Bermak J, Mao L, Rodriguez S, et al
    Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory analysis of the PRIDE study.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30264.
    PubMed     Text format     Abstract available


  95. LLERENA K, Reddy LF, Kern RS
    The role of experiential and expressive negative symptoms on job obtainment and work outcome in individuals with schizophrenia.
    Schizophr Res. 2017 Jun 6. pii: S0920-9964(17)30329.
    PubMed     Text format     Abstract available


  96. SEARLES S, Makarewicz JA, Dumas JA
    The role of estradiol in schizophrenia diagnosis and symptoms in postmenopausal women.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30299.
    PubMed     Text format     Abstract available


  97. DEAN DJ, Samson AT, Newberry R, Mittal VA, et al
    Motion energy analysis reveals altered body movement in youth at risk for psychosis.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30310.
    PubMed     Text format     Abstract available


  98. WANG S, Zhang Y, Lv L, Wu R, et al
    Abnormal regional homogeneity as a potential imaging biomarker for adolescent-onset schizophrenia: A resting-state fMRI study and support vector machine analysis.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30315.
    PubMed     Text format     Abstract available


  99. BEASLEY CL, Honer WG, Ramos-Miguel A, Vila-Rodriguez F, et al
    Prefrontal fatty acid composition in schizophrenia and bipolar disorder: Association with reelin expression.
    Schizophr Res. 2017 Jun 2. pii: S0920-9964(17)30309.
    PubMed     Text format     Abstract available


  100. KAMP D, Engelke C, Wobrock T, Kunze B, et al
    Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30312.
    PubMed     Text format    


  101. TAKAHASHI H, Kamio Y
    Acoustic startle response and its modulation in schizophrenia and autism spectrum disorder in Asian subjects.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30308.
    PubMed     Text format     Abstract available


  102. HORAT SK, Favre G, Prevot A, Ventura J, et al
    Impaired social cognition in schizophrenia during the Ultimatum Game: An EEG study.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30311.
    PubMed     Text format     Abstract available


    May 2017
  103. HASTRUP LH, Haahr UH, Jansen JE, Simonsen E, et al
    Determinants of duration of untreated psychosis among first-episode psychosis patients in Denmark: A nationwide register-based study.
    Schizophr Res. 2017 May 31. pii: S0920-9964(17)30301.
    PubMed     Text format     Abstract available


  104. SCHALINSKI I, Teicher MH, Carolus AM, Rockstroh B, et al
    Defining the impact of childhood adversities on cognitive deficits in psychosis: An exploratory analysis.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30273.
    PubMed     Text format     Abstract available


  105. NEUHAUS AH, Popescu FC
    Impact of sample size and matching on single-subject classification of schizophrenia: A meta-analysis.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30300.
    PubMed     Text format    


  106. VYAS NS, Buchsbaum MS, Lehrer DS, Merrill BM, et al
    D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naive patients with schizophrenia.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30276.
    PubMed     Text format     Abstract available


  107. SWERDLOW NR, Light GA, Thomas ML, Sprock J, et al
    Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension.
    Schizophr Res. 2017 May 23. pii: S0920-9964(17)30272.
    PubMed     Text format     Abstract available


  108. LOUISE S, Fitzpatrick M, Strauss C, Rossell SL, et al
    Mindfulness- and acceptance-based interventions for psychosis: Our current understanding and a meta-analysis.
    Schizophr Res. 2017 May 22. pii: S0920-9964(17)30298.
    PubMed     Text format     Abstract available


  109. BUONOCORE M, Spangaro M, Bechi M, Baraldi MA, et al
    Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5years.
    Schizophr Res. 2017 May 22. pii: S0920-9964(17)30297.
    PubMed     Text format     Abstract available


  110. PERRIN MA, Kantrowitz JT, Silipo G, Dias E, et al
    Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia.
    Schizophr Res. 2017 May 19. pii: S0920-9964(17)30271.
    PubMed     Text format     Abstract available


  111. FORCELLINI G, O'Donoghue S, Kenney J, McInerney S, et al
    Structural connectivity and rich-club organization in recent onset psychosis.
    Schizophr Res. 2017 May 17. pii: S0920-9964(17)30277.
    PubMed     Text format    


  112. GIANNITELLI M, Consoli A, Raffin M, Jardri R, et al
    An overview of medical risk factors for childhood psychosis: Implications for research and treatment.
    Schizophr Res. 2017 May 16. pii: S0920-9964(17)30270.
    PubMed     Text format     Abstract available


  113. FLIPPO KH, Strack S
    An emerging role for mitochondrial dynamics in schizophrenia.
    Schizophr Res. 2017 May 16. pii: S0920-9964(17)30261.
    PubMed     Text format     Abstract available


  114. SALISBURY DF, McCathern AG, Coffman BA, Murphy TK, et al
    Complex mismatch negativity to tone pair deviants in long-term schizophrenia and in the first-episode schizophrenia spectrum.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30253.
    PubMed     Text format     Abstract available


  115. HARVEY PD, Rosenthal JB
    Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30268.
    PubMed     Text format     Abstract available


  116. CROCKER CE, Tibbo PG
    The interaction of gender and cannabis in early phase psychosis.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30255.
    PubMed     Text format     Abstract available


  117. RABIN RA, Kozak K, Zakzanis KK, Remington G, et al
    A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30265.
    PubMed     Text format     Abstract available


  118. JOO SW, Chon MW, Rathi Y, Shenton ME, et al
    Abnormal asymmetry of white matter tracts between ventral posterior cingulate cortex and middle temporal gyrus in recent-onset schizophrenia.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30267.
    PubMed     Text format     Abstract available


  119. MARTINELLI C, Rigoli F, Averbeck B, Shergill SS, et al
    The value of novelty in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30266.
    PubMed     Text format     Abstract available


  120. ROSSI A, Amore M, Galderisi S, Rocca P, et al
    The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30247.
    PubMed     Text format     Abstract available


  121. LEE BS, McIntyre RS, Gentle JE, Park NS, et al
    A computational algorithm for personalized medicine in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30260.
    PubMed     Text format     Abstract available


  122. XIAO X, Yu H, Li J, Wang L, et al
    Further evidence for the association between LRP8 and schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30262.
    PubMed     Text format     Abstract available


  123. CHIAPPELLI J, Chen S, Hackman A, Elliot Hong L, et al
    Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population.
    Schizophr Res. 2017 May 6. pii: S0920-9964(17)30263.
    PubMed     Text format     Abstract available


  124. RATHEESH A, Cotton SM, Davey CG, Lin A, et al
    Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.
    Schizophr Res. 2017 May 4. pii: S0920-9964(17)30223.
    PubMed     Text format     Abstract available


  125. KASKIE RE, Ferrarelli F
    Investigating the neurobiology of schizophrenia and other major psychiatric disorders with Transcranial Magnetic Stimulation.
    Schizophr Res. 2017 May 3. pii: S0920-9964(17)30254.
    PubMed     Text format     Abstract available


  126. CAROL EE, Mittal VA
    Corrigendum to "self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado" [Schizophr. Res. 157 (0) (August 2014) 317-318].
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30248.
    PubMed     Text format    


  127. KUNUTSOR SK, Laukkanen T, Laukkanen JA
    Cardiorespiratory fitness is associated with reduced risk of future psychosis: A long-term prospective cohort study.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30249.
    PubMed     Text format    


  128. LIU Y, Zhang Y, Lv L, Wu R, et al
    Abnormal neural activity as a potential biomarker for drug-naive first-episode adolescent-onset schizophrenia with coherence regional homogeneity and support vector machine analyses.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30215.
    PubMed     Text format     Abstract available


  129. PANDEY GN, Rizavi HS, Zhang H, Ren X, et al
    Abnormal gene and protein expression of inflammatory cytokines in the postmortem brain of schizophrenia patients.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30252.
    PubMed     Text format     Abstract available


    April 2017
  130. PEDROS ROSELLO A
    Clinical and cognitive insight in patients with psychosis. Is there a relationship?
    Schizophr Res. 2017 Apr 28. pii: S0920-9964(17)30209.
    PubMed     Text format    


  131. MANTERE O, Saarela M, Kieseppa T, Raij T, et al
    Anti-neuronal anti-bodies in patients with early psychosis.
    Schizophr Res. 2017 Apr 28. pii: S0920-9964(17)30214.
    PubMed     Text format     Abstract available


  132. RANDENIYA R, Oestreich LKL, Garrido MI
    Sensory prediction errors in the continuum of psychosis.
    Schizophr Res. 2017 Apr 27. pii: S0920-9964(17)30206.
    PubMed     Text format     Abstract available


  133. MISIAK B, Stanczykiewicz B, Laczmanski L, Frydecka D, et al
    Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: Authors' reply.
    Schizophr Res. 2017 Apr 26. pii: S0920-9964(17)30219.
    PubMed     Text format    


  134. MCDONNELL J, Stahl D, Day F, McGuire P, et al
    Interpersonal sensitivity in those at clinical high risk for psychosis mediates the association between childhood bullying victimisation and paranoid ideation: A virtual reality study.
    Schizophr Res. 2017 Apr 26. pii: S0920-9964(17)30216.
    PubMed     Text format     Abstract available


  135. RAWAT VS, Ganesh S, Bijjal S, Shanivaram Reddy K, et al
    Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Schizophr Res. 2017 Apr 25. pii: S0920-9964(17)30246.
    PubMed     Text format     Abstract available


  136. GUPTA T, Hespos SJ, Horton WS, Mittal VA, et al
    Automated analysis of written narratives reveals abnormalities in referential cohesion in youth at ultra high risk for psychosis.
    Schizophr Res. 2017 Apr 25. pii: S0920-9964(17)30212.
    PubMed     Text format     Abstract available


  137. SCHWARZ E, Maukonen J, Hyytiainen T, Kieseppa T, et al
    Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30204.
    PubMed     Text format     Abstract available


  138. OHMURO N, Katsura M, Obara C, Kikuchi T, et al
    The relationship between cognitive insight and cognitive performance among individuals with at-risk mental state for developing psychosis.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30217.
    PubMed     Text format     Abstract available


  139. GERAETS CNW, van Beilen M, Pot-Kolder R, Counotte J, et al
    Social environments and interpersonal distance regulation in psychosis: A virtual reality study.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30221.
    PubMed     Text format     Abstract available


  140. LIU J, Chen J, Perrone-Bizzozero NI, Turner JA, et al
    Regional enrichment analyses on genetic profiles for schizophrenia and bipolar disorder.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30220.
    PubMed     Text format     Abstract available


  141. TSAI MT, Chang TH, Wu BJ
    Prognostic impact of nutritional risk assessment in patients with chronic schizophrenia.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30198.
    PubMed     Text format     Abstract available


  142. PAWELCZYK A, Kotlicka-Antczak M, Lojek E, Ruszpel A, et al
    Schizophrenia patients have higher-order language and extralinguistic impairments.
    Schizophr Res. 2017 Apr 21. pii: S0920-9964(17)30218.
    PubMed     Text format     Abstract available


  143. PREMKUMAR P, Bream D, Sapara A, Fannon D, et al
    Pituitary volume reduction in schizophrenia following cognitive behavioural therapy.
    Schizophr Res. 2017 Apr 20. pii: S0920-9964(17)30222.
    PubMed     Text format     Abstract available


  144. BRADSHAW NJ, Trossbach SV, Kober S, Walter S, et al
    Disrupted in Schizophrenia 1 regulates the processing of reelin in the perinatal cortex.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30200.
    PubMed     Text format     Abstract available


  145. GEORGIADES A, Davis VG, Atkins AS, Khan A, et al
    Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30180.
    PubMed     Text format     Abstract available


  146. ZURAWEK D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, et al
    Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30201.
    PubMed     Text format     Abstract available


  147. NABER D, Baker RA, Eramo A, Forray C, et al
    Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30199.
    PubMed     Text format     Abstract available


  148. LIBUY N, de Angel V, Ibanez C, Murray RM, et al
    The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services.
    Schizophr Res. 2017 Apr 18. pii: S0920-9964(17)30197.
    PubMed     Text format     Abstract available


  149. LI J, Yoshikawa A, Brennan MD, Ramsey TL, et al
    Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
    Schizophr Res. 2017 Apr 18. pii: S0920-9964(17)30196.
    PubMed     Text format     Abstract available


  150. VARGAS T, Mittal V
    Issues affecting reliable and valid assessment of early life stressors in psychosis.
    Schizophr Res. 2017 Apr 17. pii: S0920-9964(17)30208.
    PubMed     Text format    


  151. DURGAM S, Earley W, Li R, Li D, et al
    Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].
    Schizophr Res. 2017 Apr 17. pii: S0920-9964(17)30207.
    PubMed     Text format    


  152. KHOKHAR JY, Dwiel LL, Henricks AM, Doucette WT, et al
    The link between schizophrenia and substance use disorder: A unifying hypothesis.
    Schizophr Res. 2017 Apr 14. pii: S0920-9964(17)30203.
    PubMed     Text format     Abstract available


  153. KIM M, Yoon YB, Lee TH, Lee TY, et al
    The effect of tDCS on auditory hallucination and P50 sensory gating in patients with schizophrenia: A pilot study.
    Schizophr Res. 2017 Apr 14. pii: S0920-9964(17)30210.
    PubMed     Text format    


  154. GRAHAM-SCHMIDT KT, Martin-Iverson MT, Waters FAV
    Self- and other-agency in people with passivity (first rank) symptoms in schizophrenia.
    Schizophr Res. 2017 Apr 13. pii: S0920-9964(17)30211.
    PubMed     Text format     Abstract available


  155. MISIAK B, Stanczykiewicz B, Kotowicz K, Rybakowski JK, et al
    Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.
    Schizophr Res. 2017 Apr 13. pii: S0920-9964(17)30202.
    PubMed     Text format     Abstract available


  156. MEZQUIDA G, Savulich G, Garcia-Rizo C, Garcia-Portilla MP, et al
    Inverse association between negative symptoms and body mass index in chronic schizophrenia.
    Schizophr Res. 2017 Apr 12. pii: S0920-9964(17)30189.
    PubMed     Text format     Abstract available


  157. HICKLING LM, Perez-Iglesias R, Ortiz-Garcia de la Foz V, Balanza-Martinez V, et al
    Tobacco smoking and its association with cognition in first episode psychosis patients.
    Schizophr Res. 2017 Apr 12. pii: S0920-9964(17)30205.
    PubMed     Text format     Abstract available


  158. KIM M, Lee TH, Kim JH, Hong H, et al
    Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis.
    Schizophr Res. 2017 Apr 8. pii: S0920-9964(17)30188.
    PubMed     Text format     Abstract available


  159. RICARTE JJ, Del Rey F, Ros L, Latorre JM, et al
    Abstract and experiential thinking differentially account for anomalous perception of reality in people with or without schizophrenia.
    Schizophr Res. 2017 Apr 7. pii: S0920-9964(17)30194.
    PubMed     Text format     Abstract available


  160. CASSETTA BD, Kim HS, Hodgins DC, McGrath DS, et al
    Disordered gambling and psychosis: Prevalence and clinical correlates.
    Schizophr Res. 2017 Apr 6. pii: S0920-9964(17)30193.
    PubMed     Text format    


  161. LI AW, Vinas-Guasch N, Hui CL, Chang WC, et al
    Verbal working memory in schizophrenia: The role of syntax in facilitating serial recall.
    Schizophr Res. 2017 Apr 6. pii: S0920-9964(17)30195.
    PubMed     Text format     Abstract available


  162. BOGGS DL, Surti TS, Esterlis I, Pittman B, et al
    Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
    Schizophr Res. 2017 Apr 6. pii: S0920-9964(17)30187.
    PubMed     Text format     Abstract available


  163. PERRY BI, Singh SP
    Letter to the Editor: Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis.
    Schizophr Res. 2017 Apr 5. pii: S0920-9964(17)30186.
    PubMed     Text format    


    March 2017
  164. ADDINGTON J, Piskulic D, Liu L, Lockwood J, et al
    Comorbid diagnoses for youth at clinical high risk of psychosis.
    Schizophr Res. 2017 Mar 31. pii: S0920-9964(17)30183.
    PubMed     Text format     Abstract available


  165. TSENG HH, Chen KC, Chen PS, Lee IH, et al
    Dopamine transporter availability in drug-naive patients with schizophrenia and later psychotic symptoms severity.
    Schizophr Res. 2017 Mar 29. pii: S0920-9964(17)30174.
    PubMed     Text format    


  166. WANG LJ, Lin PY, Lee Y, Huang YC, et al
    Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
    Schizophr Res. 2017 Mar 28. pii: S0920-9964(17)30181.
    PubMed     Text format     Abstract available


  167. TAN EJ, Rossell SL
    Formal thought disorder and neurocognition in schizophrenia: The question of individual mechanisms.
    Schizophr Res. 2017 Mar 28. pii: S0920-9964(17)30179.
    PubMed     Text format    


  168. MACHIELSEN MW, Veltman DJ, van den Brink W, de Haan L, et al
    Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
    Schizophr Res. 2017 Mar 25. pii: S0920-9964(17)30168.
    PubMed     Text format     Abstract available


  169. CORRELL CU, Skuban A, Hobart M, Ouyang J, et al
    Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92].
    Schizophr Res. 2017 Mar 25. pii: S0920-9964(17)30120.
    PubMed     Text format    


  170. LENZI J, Iozzino L, De Girolamo G, Rucci P, et al
    Predictors of 9-month hospitalization in patients with first-episode affective and non-affective psychosis. Results from the GET UP pragmatic cluster randomized controlled trial.
    Schizophr Res. 2017 Mar 24. pii: S0920-9964(17)30178.
    PubMed     Text format    


  171. POTKIN SG, Risinger R, Du Y, Zummo J, et al
    Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation.
    Schizophr Res. 2017 Mar 22. pii: S0920-9964(17)30124.
    PubMed     Text format     Abstract available


  172. CHEN CH, Cheng MC, Liu CM, Liu CC, et al
    Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia.
    Schizophr Res. 2017 Mar 21. pii: S0920-9964(17)30134.
    PubMed     Text format     Abstract available


  173. JAHSHAN C, Wynn JK, Mathalon DH, Green MF, et al
    Cognitive correlates of visual neural plasticity in schizophrenia.
    Schizophr Res. 2017 Mar 20. pii: S0920-9964(17)30133.
    PubMed     Text format     Abstract available


  174. CHOI SH, Kyeong S, Cho KI, Yun JY, et al
    Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis.
    Schizophr Res. 2017 Mar 18. pii: S0920-9964(17)30166.
    PubMed     Text format     Abstract available


  175. MISIAK B, Stanczykiewicz B, Laczmanski L, Frydecka D, et al
    Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2017 Mar 18. pii: S0920-9964(17)30169.
    PubMed     Text format     Abstract available


  176. STEGMAYER K, Strik W, Federspiel A, Wiest R, et al
    Specific cerebral perfusion patterns in three schizophrenia symptom dimensions.
    Schizophr Res. 2017 Mar 17. pii: S0920-9964(17)30131.
    PubMed     Text format     Abstract available


  177. KLINE E, Keshavan M
    Innovations in first episode psychosis interventions: The case for a "RAISE-Plus" approach.
    Schizophr Res. 2017 Mar 17. pii: S0920-9964(17)30173.
    PubMed     Text format     Abstract available


  178. KANTROWITZ JT, Epstein ML, Lee M, Lehrfeld N, et al
    Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
    Schizophr Res. 2017 Mar 17. pii: S0920-9964(17)30116.
    PubMed     Text format     Abstract available


  179. FLETCHER PJ, Li Z, Coen KM, Le AD, et al
    Acquisition of nicotine self-administration in amphetamine and phencyclidine models of schizophrenia: A role for stress?
    Schizophr Res. 2017 Mar 16. pii: S0920-9964(17)30117.
    PubMed     Text format     Abstract available


  180. LUNSFORD-AVERY JR, Dean DJ, Mittal VA
    Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis.
    Schizophr Res. 2017 Mar 16. pii: S0920-9964(17)30162.
    PubMed     Text format     Abstract available


  181. REAVIS EA, Lee J, Wynn JK, Narr KL, et al
    Linking optic radiation volume to visual perception in schizophrenia and bipolar disorder.
    Schizophr Res. 2017 Mar 16. pii: S0920-9964(17)30165.
    PubMed     Text format     Abstract available


  182. SCHOFIELD P, Thygesen M, Das-Munshi J, Becares L, et al
    Ethnic density, urbanicity and psychosis risk for migrant groups - A population cohort study.
    Schizophr Res. 2017 Mar 15. pii: S0920-9964(17)30170.
    PubMed     Text format     Abstract available


  183. ZHAI D, Lang Y, Feng Y, Liu Y, et al
    Early onset of cardiometabolic risk factor profiles in drug naive adolescents and young adults with first-episode schizophrenia.
    Schizophr Res. 2017 Mar 15. pii: S0920-9964(17)30126.
    PubMed     Text format     Abstract available


  184. LUDWIG KA, Pinkham AE, Harvey PD, Kelsven S, et al
    Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30121.
    PubMed     Text format     Abstract available


  185. FU S, Czajkowski N, Rund BR, Torgalsboen AK, et al
    The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30122.
    PubMed     Text format     Abstract available


  186. BORA E
    Relationship between insight and theory of mind in schizophrenia: A meta-analysis.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30167.
    PubMed     Text format     Abstract available


  187. KOSHIYAMA D, Kirihara K, Tada M, Nagai T, et al
    Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30132.
    PubMed     Text format     Abstract available


  188. ABORAYA A, Leucht S, Nasrallah HH, Samara M, et al
    A novel approach to measuring response and remission in schizophrenia in clinical trials.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30139.
    PubMed     Text format     Abstract available


  189. KOZAK K, Dermody SS, Rabin RA, Zack M, et al
    Effects of varenicline on cognitive function in non-smokers with schizophrenia.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30143.
    PubMed     Text format    


  190. AWAN NR, Jehangir SF, Irfan M, Naeem F, et al
    Explanatory model of illness of the patients with schizophrenia and the role of educational intervention.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30125.
    PubMed     Text format     Abstract available


  191. EACK SM, Wojtalik JA, Keshavan MS, Minshew NJ, et al
    Social-cognitive brain function and connectivity during visual perspective-taking in autism and schizophrenia.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30130.
    PubMed     Text format     Abstract available


  192. BARBATO M, Buchy L, Bray S, MacMaster F, et al
    Testing the feasibility of a computerized facial affect recognition training in early psychosis.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30137.
    PubMed     Text format    


  193. KHOKHAR JY, Todd TP
    Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30118.
    PubMed     Text format     Abstract available


  194. OKRUSZEK L, Pilecka I
    Biological motion processing in schizophrenia - Systematic review and meta-analysis.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30135.
    PubMed     Text format     Abstract available


  195. VALAPARLA VL, Nehra R, Mehta UM, Thirthalli J, et al
    Social cognition of patients with schizophrenia across the phases of illness - A longitudinal study.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30123.
    PubMed     Text format     Abstract available


  196. TAKASE M, Kanahara N, Oda Y, Niitsu T, et al
    The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30136.
    PubMed     Text format    


  197. HARTZ SM, Horton AC, Hancock DB, Baker TB, et al
    Genetic correlation between smoking behaviors and schizophrenia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30111.
    PubMed     Text format     Abstract available


  198. GALLETLY C, Dhillon VS, Liu D, Balzan RP, et al
    Shorter telomere length in people with schizophrenia: A preliminary study from Australia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30128.
    PubMed     Text format     Abstract available


  199. RABIN RA, Kozak K, Zakzanis KK, Remington G, et al
    Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30129.
    PubMed     Text format     Abstract available


  200. LAXHMAN N, Greenberg L, Priebe S
    Satisfaction with sex life among patients with schizophrenia.
    Schizophr Res. 2017 Mar 5. pii: S0920-9964(17)30127.
    PubMed     Text format     Abstract available


  201. MWANSISYA TE, Hu A, Li Y, Chen X, et al
    Task and resting-state fMRI studies in first-episode schizophrenia: A systematic review.
    Schizophr Res. 2017 Mar 3. pii: S0920-9964(17)30115.
    PubMed     Text format     Abstract available


  202. FRAGUAS D, Diaz-Caneja CM, Corripio I, Gonzalez-Pinto A, et al
    Gene-environment interaction as a predictor of early adjustment in first episode psychosis.
    Schizophr Res. 2017 Mar 2. pii: S0920-9964(17)30110.
    PubMed     Text format     Abstract available


  203. DELISI LE
    Predicting Psychosis with Accuracy.
    Schizophr Res. 2017;181:4-5.
    PubMed     Text format    


    February 2017
  204. BROWN AS, Meyer U
    Comment on: "The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: Critical review and meta-analysis".
    Schizophr Res. 2017 Feb 27. pii: S0920-9964(17)30112.
    PubMed     Text format    


  205. YUKSEL P, Kocazeybek B, Ozdemir A, Yolken RH, et al
    Stability of Toxoplasma gondii: Antibody levels in schizophrenia.
    Schizophr Res. 2017 Feb 27. pii: S0920-9964(17)30080.
    PubMed     Text format    


  206. BUKENAITE A, Stochl J, Mossaheb N, Schafer MR, et al
    Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.
    Schizophr Res. 2017 Feb 26. pii: S0920-9964(17)30103.
    PubMed     Text format     Abstract available


  207. CHUNG Y, Haut KM, He G, van Erp TG, et al
    Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
    Schizophr Res. 2017 Feb 25. pii: S0920-9964(17)30100.
    PubMed     Text format     Abstract available


  208. JOHN J, Kukshal P, Bhatia T, Chowdari KV, et al
    Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia.
    Schizophr Res. 2017 Feb 24. pii: S0920-9964(17)30109.
    PubMed     Text format     Abstract available


  209. VAN ROOIJEN G, Isvoranu AM, Meijer CJ, van Borkulo CD, et al
    A symptom network structure of the psychosis spectrum.
    Schizophr Res. 2017 Feb 22. pii: S0920-9964(17)30104.
    PubMed     Text format     Abstract available


  210. POUSA E, Ochoa S, Cobo J, Nieto L, et al
    A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors.
    Schizophr Res. 2017 Feb 22. pii: S0920-9964(17)30101.
    PubMed     Text format     Abstract available


  211. HAN S, Zong X, Hu M, Yu Y, et al
    Frequency-selective alteration in the resting-state corticostriatal-thalamo-cortical circuit correlates with symptoms severity in first-episode drug-naive patients with schizophrenia.
    Schizophr Res. 2017 Feb 21. pii: S0920-9964(17)30108.
    PubMed     Text format     Abstract available


  212. CRESPO-FACORRO B, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, Valdizan EM, et al
    Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.
    Schizophr Res. 2017 Feb 17. pii: S0920-9964(17)30059.
    PubMed     Text format     Abstract available


  213. CANTILLON M, Prakash A, Alexander A, Ings R, et al
    Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.
    Schizophr Res. 2017 Feb 16. pii: S0920-9964(17)30056.
    PubMed     Text format     Abstract available


  214. LEWINE R, Martin M, Hart M
    Sex versus gender differences in schizophrenia: The case for normal personality differences.
    Schizophr Res. 2017 Feb 16. pii: S0920-9964(17)30102.
    PubMed     Text format     Abstract available


  215. QUIDE Y, Ong XH, Mohnke S, Schnell K, et al
    Childhood trauma-related alterations in brain function during a Theory-of-Mind task in schizophrenia.
    Schizophr Res. 2017 Feb 15. pii: S0920-9964(17)30083.
    PubMed     Text format     Abstract available


  216. ITTIG S, Studerus E, Heitz U, Menghini-Muller S, et al
    Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30081.
    PubMed     Text format     Abstract available


  217. RODRIGUES R, Anderson KK
    The traumatic experience of first-episode psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30058.
    PubMed     Text format     Abstract available


  218. WEINSTEIN Y, Gelkopf M, Roe D, Levine SZ, et al
    The effect of different terror exposures on the course of schizophrenia: A twenty-year follow-up of a random sample.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30075.
    PubMed     Text format    


  219. LOPEZ-GIMENEZ JF, de la Fuente Revenga M, Ruso-Julve F, Saunders JM, et al
    Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy.
    Schizophr Res. 2017 Feb 12. pii: S0920-9964(17)30076.
    PubMed     Text format    


  220. OESTREICH LK, Lyall AE, Pasternak O, Kikinis Z, et al
    Characterizing white matter changes in chronic schizophrenia: A free-water imaging multi-site study.
    Schizophr Res. 2017 Feb 10. pii: S0920-9964(17)30077.
    PubMed     Text format     Abstract available


  221. GEISER E, Retsa C, Knebel JF, Ferrari C, et al
    The coupling of low-level auditory dysfunction and oxidative stress in psychosis patients.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30073.
    PubMed     Text format     Abstract available


  222. ROBERTS RC
    Postmortem studies on mitochondria in schizophrenia.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30070.
    PubMed     Text format     Abstract available


  223. BRIEND F, Leroux E, Delcroix N, Razafimandimby A, et al
    Impact of rTMS on functional connectivity within the language network in schizophrenia patients with auditory hallucinations.
    Schizophr Res. 2017 Feb 8. pii: S0920-9964(17)30067.
    PubMed     Text format     Abstract available


  224. MEZQUIDA G, Cabrera B, Bioque M, Amoretti S, et al
    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30060.
    PubMed     Text format     Abstract available


  225. LY D, DeLisi LE
    Can antibiotics cause a psychosis?: Case report and review of the literature.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30054.
    PubMed     Text format     Abstract available


  226. MUELLER DR, Khalesi Z, Benzing V, Castiglione CI, et al
    Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30050.
    PubMed     Text format     Abstract available


  227. GLAUSIER JR, Lewis DA
    GABA and schizophrenia: Where we stand and where we need to go.
    Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30066.
    PubMed     Text format    


  228. BERNARDO M, Bioque M, Cabrera B, Lobo A, et al
    Modelling gene-environment interaction in first episodes of psychosis.
    Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30068.
    PubMed     Text format     Abstract available


  229. SHARMA A, Vogel M, Weisbrod M, Roesch-Ely D, et al
    Pronounced inhibition-related hypofrontal dysfunction in early-onset schizophrenia as indexed by NoGo-P300 amplitude.
    Schizophr Res. 2017 Feb 4. pii: S0920-9964(17)30074.
    PubMed     Text format    


  230. LUNSFORD-AVERY JR, Goncalves BD, Brietzke E, Bressan RA, et al
    Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Schizophr Res. 2017 Feb 4. pii: S0920-9964(17)30065.
    PubMed     Text format     Abstract available


  231. ALUSTIZA I, Radua J, Pla M, Martin R, et al
    Meta-analysis of functional magnetic resonance imaging studies of timing and cognitive control in schizophrenia and bipolar disorder: Evidence of a primary time deficit.
    Schizophr Res. 2017 Feb 3. pii: S0920-9964(17)30052.
    PubMed     Text format     Abstract available


  232. BUCHY L, Barbato M, Makowski C, Bray S, et al
    Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study.
    Schizophr Res. 2017 Feb 3. pii: S0920-9964(17)30062.
    PubMed     Text format     Abstract available


    January 2017
  233. BARR MS, Rajji TK, Zomorrodi R, Radhu N, et al
    Impaired theta-gamma coupling during working memory performance in schizophrenia.
    Schizophr Res. 2017 Jan 29. pii: S0920-9964(17)30057.
    PubMed     Text format     Abstract available


  234. GREENLAND-WHITE SE, Ragland JD, Niendam TA, Ferrer E, et al
    Episodic memory functions in first episode psychosis and clinical high risk individuals.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30048.
    PubMed     Text format     Abstract available


  235. ALONSO-SOLIS A, Vives-Gilabert Y, Portella MJ, Rabella M, et al
    Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30055.
    PubMed     Text format     Abstract available


  236. HENGARTNER MP, Heekeren K, Dvorsky D, Walitza S, et al
    Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30053.
    PubMed     Text format     Abstract available


  237. JOSEPH J, Kremen WS, Franz CE, Glatt SJ, et al
    Predictors of current functioning and functional decline in schizophrenia.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30051.
    PubMed     Text format     Abstract available


  238. ZENG L, Kang C, Yuan J, Zhang Y, et al
    CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.
    Schizophr Res. 2017 Jan 26. pii: S0920-9964(17)30043.
    PubMed     Text format    


  239. FILATOVA S, Koivumaa-Honkanen H, Hirvonen N, Freeman A, et al
    Early motor developmental milestones and schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30042.
    PubMed     Text format     Abstract available


  240. HARBER L, Takeuchi H, Borlido C, Hamidian R, et al
    Factors associated with drug attitude in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30046.
    PubMed     Text format    


  241. CHANG X, Collin G, Xi Y, Cui L, et al
    Resting-state functional connectivity in medication-naive schizophrenia patients with and without auditory verbal hallucinations: A preliminary report.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30037.
    PubMed     Text format     Abstract available


  242. KESHAVAN MS, Sudarshan M
    Deep dreaming, aberrant salience and psychosis: Connecting the dots by artificial neural networks.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30029.
    PubMed     Text format     Abstract available


  243. EMSLEY R, Chiliza B, Asmal L, Kilian S, et al
    Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30047.
    PubMed     Text format     Abstract available


  244. SMESNY S, Milleit B, Schaefer MR, Hesse J, et al
    Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
    Schizophr Res. 2017 Jan 23. pii: S0920-9964(17)30039.
    PubMed     Text format     Abstract available


  245. VINCENT PD, Demers MF, Doyon-Kemp V, Duchesneau J, et al
    One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30026.
    PubMed     Text format     Abstract available


  246. FIKSINSKI AM, Breetvelt EJ, Duijff SN, Bassett AS, et al
    Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30044.
    PubMed     Text format     Abstract available


  247. KIM SW, Polari A, Melville F, Moller B, et al
    Are current labeling terms suitable for people who are at risk of psychosis?
    Schizophr Res. 2017 Jan 20. pii: S0920-9964(17)30040.
    PubMed     Text format     Abstract available


  248. PARK CH, Lee S, Kim T, Won WY, et al
    Different alterations in brain functional networks according to direct and indirect topological connections in patients with schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30038.
    PubMed     Text format     Abstract available


  249. ANDRIANARISOA M, Boyer L, Godin O, Brunel L, et al
    Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(16)30596.
    PubMed     Text format     Abstract available


  250. LIN CH, Wang FC, Lin SC, Huang YH, et al
    A randomized, double-blind, comparison of the efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine versus full-dose olanzapine in the acute treatment of schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30004.
    PubMed     Text format     Abstract available


  251. D'ADDARIO C, Micale V, Di Bartolomeo M, Stark T, et al
    A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30031.
    PubMed     Text format     Abstract available


  252. KU HL, Wang JK, Lee HC, Lane TJ, et al
    Cerebral blood flow autoregulation is impaired in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30024.
    PubMed     Text format     Abstract available


  253. BAI Z, Wang G, Cai S, Ding X, et al
    Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30001.
    PubMed     Text format     Abstract available


  254. WU CHOU AI, Wang YC, Lin CL, Kao CH, et al
    Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30028.
    PubMed     Text format     Abstract available


  255. PINTO JV, Passos IC, Gomes F, Reckziegel R, et al
    Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach.
    Schizophr Res. 2017 Jan 16. pii: S0920-9964(17)30023.
    PubMed     Text format    


  256. ALI FT, Abd El-Azeem EM, Hamed MA, Ali MA, et al
    Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
    Schizophr Res. 2017 Jan 15. pii: S0920-9964(17)30027.
    PubMed     Text format     Abstract available


  257. BORDON N, O'Rourke S, Hutton P
    The feasibility and clinical benefits of improving facial affect recognition impairments in schizophrenia: Systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 14. pii: S0920-9964(17)30025.
    PubMed     Text format     Abstract available


  258. GROT S, Legare VP, Lipp O, Soulieres I, et al
    Abnormal prefrontal and parietal activity linked to deficient active binding in working memory in schizophrenia.
    Schizophr Res. 2017 Jan 14. pii: S0920-9964(17)30030.
    PubMed     Text format     Abstract available


  259. LINDENMAYER JP, Fregenti S, Kang G, Ozog V, et al
    The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(17)30008.
    PubMed     Text format     Abstract available


  260. NARLA ST, Lee YW, Benson CA, Sarder P, et al
    Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(16)30568.
    PubMed     Text format     Abstract available


  261. JARSKOG LF, Pedersen CA, Johnson JL, Hamer RM, et al
    A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(17)30007.
    PubMed     Text format     Abstract available


  262. MARTINEZ G, Alexandre C, Mam-Lam-Fook C, Bendjemaa N, et al
    Phenotypic continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of Social Cognition (MASC).
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30013.
    PubMed     Text format     Abstract available


  263. KUMAR V, Venkatasubramanian G
    Extended (alternate day) antipsychotic dosing and dopamine supersensitivity psychosis: A case report.
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30009.
    PubMed     Text format    


  264. BLANCHARD JJ, Bradshaw KR, Garcia CP, Nasrallah HA, et al
    Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30011.
    PubMed     Text format     Abstract available


  265. DONG D, Wang Y, Chang X, Jiang Y, et al
    Shared abnormality of white matter integrity in schizophrenia and bipolar disorder: A comparative voxel-based meta-analysis.
    Schizophr Res. 2017 Jan 9. pii: S0920-9964(17)30005.
    PubMed     Text format     Abstract available


  266. SHOVESTUL BJ, Glassman M, Rowland LM, McMahon RP, et al
    Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia.
    Schizophr Res. 2017 Jan 9. pii: S0920-9964(16)30601.
    PubMed     Text format    


  267. HAHN B, Harvey AN, Gold JM, Ross TJ, et al
    Load-dependent hyperdeactivation of the default mode network in people with schizophrenia.
    Schizophr Res. 2017 Jan 7. pii: S0920-9964(17)30002.
    PubMed     Text format     Abstract available


  268. BALAN S, Yamada K, Iwayama Y, Hashimoto T, et al
    Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia.
    Schizophr Res. 2017 Jan 7. pii: S0920-9964(17)30003.
    PubMed     Text format     Abstract available


  269. BENOIT A, Bowie CR, Lepage M
    Is cognitive insight relevant to functional capacity in schizophrenia?
    Schizophr Res. 2017 Jan 6. pii: S0920-9964(16)30569.
    PubMed     Text format    


  270. CONUS P, Cotton SM, Francey SM, O'Donoghue B, et al
    Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Schizophr Res. 2017 Jan 5. pii: S0920-9964(16)30605.
    PubMed     Text format     Abstract available


  271. AGNEW-BLAIS J, Seidman LJ, Fitzmaurice GM, Smoller JW, et al
    The interplay of childhood behavior problems and IQ in the development of later schizophrenia and affective psychoses.
    Schizophr Res. 2017 Jan 3. pii: S0920-9964(16)30570.
    PubMed     Text format     Abstract available


  272. MELLOR-MARSA B, Caballero FF, Cabello M, Ayuso-Mateos JL, et al
    Disability multilevel modelling in first episodes of psychosis at 3-year follow-up.
    Schizophr Res. 2017 Jan 3. pii: S0920-9964(16)30588.
    PubMed     Text format     Abstract available


    December 2016
  273. LYSTAD JU, Falkum E, Haaland VO, Bull H, et al
    Cognitive remediation and occupational outcome in schizophrenia spectrum disorders: A 2year follow-up study.
    Schizophr Res. 2016 Dec 29. pii: S0920-9964(16)30594.
    PubMed     Text format     Abstract available


  274. TASIC L, Pontes JG, Carvalho MS, Cruz G, et al
    Metabolomics and lipidomics analyses by 1H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis.
    Schizophr Res. 2016 Dec 28. pii: S0920-9964(16)30599.
    PubMed     Text format     Abstract available


  275. MORANDI S, Golay P, Lambert M, Schimmelmann BG, et al
    Community Treatment Order: Identifying the need for more evidence based justification of its use in first episode psychosis patients.
    Schizophr Res. 2016 Dec 27. pii: S0920-9964(16)30597.
    PubMed     Text format     Abstract available


  276. KESHAVAN MS, DeLisi LE, Nasrallah HA
    Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading.
    Schizophr Res. 2016 Dec 27. pii: S0920-9964(16)30547.
    PubMed     Text format    


  277. YALINCETIN B, Bora E, Binbay T, Ulas H, et al
    Formal thought disorder in schizophrenia and bipolar disorder: A systematic review and meta-analysis.
    Schizophr Res. 2016 Dec 22. pii: S0920-9964(16)30589.
    PubMed     Text format     Abstract available


  278. ABE D, Arai M, Itokawa M
    Music-evoked emotions in schizophrenia.
    Schizophr Res. 2016 Dec 22. pii: S0920-9964(16)30587.
    PubMed     Text format     Abstract available


  279. BOPP MH, Zollner R, Jansen A, Dietsche B, et al
    White matter integrity and symptom dimensions of schizophrenia: A diffusion tensor imaging study.
    Schizophr Res. 2016 Dec 21. pii: S0920-9964(16)30556.
    PubMed     Text format     Abstract available


  280. GANELLA EP, Bartholomeusz CF, Seguin C, Whittle S, et al
    Functional brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2016 Dec 20. pii: S0920-9964(16)30566.
    PubMed     Text format     Abstract available


  281. KRAKOWSKI MI, Czobor P
    Proneness to aggression and its inhibition in schizophrenia: Interconnections between personality traits, cognitive function and emotional processing.
    Schizophr Res. 2016 Dec 19. pii: S0920-9964(16)30548.
    PubMed     Text format     Abstract available


  282. MILLMAN ZB, Weintraub MJ, Bentley E, DeVylder JE, et al
    Differential relations of locus of control to perceived social stress among help-seeking adolescents at low vs. high clinical risk of psychosis.
    Schizophr Res. 2016 Dec 17. pii: S0920-9964(16)30563.
    PubMed     Text format     Abstract available


  283. NEILSON E, Bois C, Gibson J, Duff B, et al
    Effects of environmental risks and polygenic loading for schizophrenia on cortical thickness.
    Schizophr Res. 2016 Dec 15. pii: S0920-9964(16)30567.
    PubMed     Text format     Abstract available


  284. BREITBORDE NJ, Maple AM, Bell EK, Dawson SC, et al
    Activity-regulated cytoskeleton-associated protein predicts response to cognitive remediation among individuals with first-episode psychosis.
    Schizophr Res. 2016 Dec 15. pii: S0920-9964(16)30564.
    PubMed     Text format    


  285. RAMANATHAN S, Mattiaccio LM, Coman IL, Botti JC, et al
    Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Schizophr Res. 2016 Dec 14. pii: S0920-9964(16)30551.
    PubMed     Text format     Abstract available


  286. CANCEL A, Comte M, Boutet C, Schneider FC, et al
    Childhood trauma and emotional processing circuits in schizophrenia: A functional connectivity study.
    Schizophr Res. 2016 Dec 13. pii: S0920-9964(16)30561.
    PubMed     Text format     Abstract available


  287. DESERNO L, Heinz A, Schlagenhauf F
    Computational approaches to schizophrenia: A perspective on negative symptoms.
    Schizophr Res. 2016 Dec 13. pii: S0920-9964(16)30448.
    PubMed     Text format     Abstract available


  288. BRATTON H, O'Rourke S, Tansey L, Hutton P, et al
    Social cognition and paranoia in forensic inpatients with schizophrenia: A cross-sectional study.
    Schizophr Res. 2016 Dec 12. pii: S0920-9964(16)30562.
    PubMed     Text format     Abstract available


  289. EVINS AE, Hoeppner SS, Schoenfeld DA, Hoeppner BB, et al
    Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
    Schizophr Res. 2016 Dec 9. pii: S0920-9964(16)30511.
    PubMed     Text format     Abstract available


  290. RAHMANZADEH R, Eftekhari S, Khodaei Ardakani MR, Rahmanzade R, et al
    Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial.
    Schizophr Res. 2016 Dec 9. pii: S0920-9964(16)30560.
    PubMed     Text format    


  291. MCCARTHY NS, Melton PE, Ward SV, Allan SM, et al
    Exome array analysis suggests an increased variant burden in families with schizophrenia.
    Schizophr Res. 2016 Dec 8. pii: S0920-9964(16)30565.
    PubMed     Text format     Abstract available


  292. SHIOZAWA P, Fasanella NA, Marinho C, Taiar I, et al
    Trigeminal nerve stimulation (TNS) for treating negative symptoms in schizophrenia: A case study.
    Schizophr Res. 2016 Dec 7. pii: S0920-9964(16)30528.
    PubMed     Text format    


  293. CURRIE A, Nelson B
    Can repetitive transcranial magnetic stimulation improve neurocognition in schizophrenia when combined with cognitive remediation?
    Schizophr Res. 2016 Dec 7. pii: S0920-9964(16)30509.
    PubMed     Text format    


  294. LAURSEN TM, Trabjerg BB, Mors O, Borglum AD, et al
    Association of the polygenic risk score for schizophrenia with mortality and suicidal behavior - A Danish population-based study.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30559.
    PubMed     Text format     Abstract available


  295. ANTICEVIC A
    Understanding the role of thalamic circuits in schizophrenia neuropathology.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30555.
    PubMed     Text format    


  296. HAHN LA, Mackinnon A, Foley DL, Morgan VA, et al
    The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30557.
    PubMed     Text format     Abstract available


  297. MECHELLI A, Lin A, Wood S, McGorry P, et al
    Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.
    Schizophr Res. 2016 Dec 3. pii: S0920-9964(16)30558.
    PubMed     Text format     Abstract available


  298. RAGAN C, Patel K, Edson J, Zhang ZH, et al
    Small non-coding RNA expression from anterior cingulate cortex in schizophrenia shows sex specific regulation.
    Schizophr Res. 2016 Dec 1. pii: S0920-9964(16)30517.
    PubMed     Text format     Abstract available


  299. SENGUPTA SM, MacDonald K, Fathalli F, Yim A, et al
    Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis.
    Schizophr Res. 2016 Dec 1. pii: S0920-9964(16)30549.
    PubMed     Text format     Abstract available


    November 2016
  300. OSBORNE KJ, Bernard JA, Gupta T, Dean DJ, et al
    Beat gestures and postural control in youth at ultrahigh risk for psychosis.
    Schizophr Res. 2016 Nov 30. pii: S0920-9964(16)30521.
    PubMed     Text format     Abstract available


  301. GIANFRANCESCO O, Warburton A, Collier DA, Bubb VJ, et al
    Novel brain expressed RNA identified at the MIR137 schizophrenia-associated locus.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30529.
    PubMed     Text format     Abstract available


  302. LIN J, Geng X, Lee EH, Chan SK, et al
    Yoga reduces the brain's amplitude of low-frequency fluctuations in patients with early psychosis results of a randomized controlled trial.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30550.
    PubMed     Text format    


  303. MOTHERSILL O, Tangney N, Morris DW, McCarthy H, et al
    Further evidence of alerted default network connectivity and association with theory of mind ability in schizophrenia.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30553.
    PubMed     Text format     Abstract available


  304. COTTER J, Lin A, Drake RJ, Thompson A, et al
    Long-term employment among people at ultra-high risk for psychosis.
    Schizophr Res. 2016 Nov 27. pii: S0920-9964(16)30526.
    PubMed     Text format     Abstract available


  305. GUMLEY A, White R, Briggs A, Ford I, et al
    A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for depression after psychosis: Pilot trial outcomes (ADAPT).
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30519.
    PubMed     Text format     Abstract available


  306. WANG C, Zhang Y
    Schizophrenia in mid-adulthood after prenatal exposure to the Chinese Famine of 1959-1961.
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30523.
    PubMed     Text format     Abstract available


  307. LEE JS, Kim CY, Joo YH, Newell D, et al
    Corrigendum to "Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition" [Schizophr. Res. 176 (2-3) (Oct 2016) 144-150].
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30494.
    PubMed     Text format    


  308. BAYLISS JK, Bodarya K, Carson CM, Miller BJ, et al
    Recurrent urinary tract infections in children and adolescents with acute psychosis.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30522.
    PubMed     Text format    


  309. COUGHLIN JM, Hayes LN, Tanaka T, Xiao M, et al
    Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30492.
    PubMed     Text format     Abstract available


  310. O'KEEFFE J, Conway R, McGuire B
    A systematic review examining factors predicting favourable outcome in cognitive behavioural interventions for psychosis.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30514.
    PubMed     Text format     Abstract available


  311. CHANG H, Li L, Li M, Xiao X, et al
    Rare and common variants at 16p11.2 are associated with schizophrenia.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30524.
    PubMed     Text format     Abstract available


  312. ASMAL L, du Plessis S, Vink M, Fouche JP, et al
    Insight and white matter fractional anisotropy in first-episode schizophrenia.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30498.
    PubMed     Text format     Abstract available


  313. COUNOTTE J, Pot-Kolder R, van Roon AM, Hoskam O, et al
    High psychosis liability is associated with altered autonomic balance during exposure to Virtual Reality social stressors.
    Schizophr Res. 2016 Nov 22. pii: S0920-9964(16)30518.
    PubMed     Text format     Abstract available


  314. BORA E, Pantelis C
    Challenges facing the identification of distinctive cognitive and neurobiological features of schizophrenia and bipolar disorder and the need for a data-driven approach: Response to Dr. Martino.
    Schizophr Res. 2016 Nov 22. pii: S0920-9964(16)30516.
    PubMed     Text format    


  315. CHO H, Gonzalez R, Lavaysse LM, Pence S, et al
    Do people with schizophrenia experience more negative emotion and less positive emotion in their daily lives? A meta-analysis of experience sampling studies.
    Schizophr Res. 2016 Nov 21. pii: S0920-9964(16)30510.
    PubMed     Text format     Abstract available


  316. MARTINO DJ, Samame C, Strejilevich SA
    Social cognition in schizophrenia and bipolar disorder: Just quantitative differences..?
    Schizophr Res. 2016 Nov 21. pii: S0920-9964(16)30515.
    PubMed     Text format    


  317. WANG SB, Wang YY, Ungvari GS, Ng CH, et al
    The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis.
    Schizophr Res. 2016 Nov 18. pii: S0920-9964(16)30512.
    PubMed     Text format     Abstract available


  318. CARNEY R, Bradshaw T, Firth J, Cotter J, et al
    Lifestyle factors may be linked to symptoms of metabolic syndrome in people at risk for psychosis.
    Schizophr Res. 2016 Nov 16. pii: S0920-9964(16)30506.
    PubMed     Text format    


  319. LIZANO PL, Yao JK, Tandon N, Mothi SS, et al
    Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30508.
    PubMed     Text format     Abstract available


  320. KOYANAGI A, Oh H, Haro JM, Hirayama F, et al
    Child death and maternal psychosis-like experiences in 44 low- and middle-income countries: The role of depression.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30505.
    PubMed     Text format     Abstract available


  321. FUJII T, Hattori K, Miyakawa T, Ohashi Y, et al
    Metabolic profile alterations in the postmortem brains of patients with schizophrenia using capillary electrophoresis-mass spectrometry.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30504.
    PubMed     Text format     Abstract available


  322. SELTEN JP, Termorshuizen F
    The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: critical review and meta-analysis.
    Schizophr Res. 2016 Nov 14. pii: S0920-9964(16)30499.
    PubMed     Text format     Abstract available


  323. AKKUS F, Treyer V, Ametamey SM, Johayem A, et al
    Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
    Schizophr Res. 2016 Nov 12. pii: S0920-9964(16)30501.
    PubMed     Text format     Abstract available


  324. DE LA SERNA E, Sugranyes G, Sanchez-Gistau V, Rodriguez-Toscano E, et al
    Neuropsychological characteristics of child and adolescent offspring of patients with schizophrenia or bipolar disorder.
    Schizophr Res. 2016 Nov 12. pii: S0920-9964(16)30500.
    PubMed     Text format     Abstract available


  325. CARSON CM, Phillip N, Miller BJ
    Urinary tract infections in children and adolescents with acute psychosis.
    Schizophr Res. 2016 Nov 10. pii: S0920-9964(16)30497.
    PubMed     Text format     Abstract available


  326. KRKOVIC K, Moritz S, Lincoln TM
    Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Schizophr Res. 2016 Nov 9. pii: S0920-9964(16)30495.
    PubMed     Text format     Abstract available


  327. BROWN AS, Gyllenberg D, Hinkka-Yli-Salomaki S, Sourander A, et al
    Altered growth trajectory of head circumference during infancy and schizophrenia in a National Birth Cohort.
    Schizophr Res. 2016 Nov 4. pii: S0920-9964(16)30476.
    PubMed     Text format     Abstract available


    October 2016
  328. BEN-SHACHAR D
    Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
    Schizophr Res. 2016 Oct 29. pii: S0920-9964(16)30466.
    PubMed     Text format     Abstract available


  329. PADMANABHAN JL, Shah JL, Tandon N, Keshavan MS, et al
    The "polyenviromic risk score": Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects.
    Schizophr Res. 2016 Oct 29. pii: S0920-9964(16)30458.
    PubMed     Text format     Abstract available


  330. RAN MS, Wong YI, Yang SY, Ho PS, et al
    Marriage and outcomes of people with schizophrenia in rural China: 14-year follow-up study.
    Schizophr Res. 2016 Oct 28. pii: S0920-9964(16)30478.
    PubMed     Text format     Abstract available


  331. WILS RS, Gotfredsen DR, Hjorthoj C, Austin SF, et al
    Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Schizophr Res. 2016 Oct 27. pii: S0920-9964(16)30474.
    PubMed     Text format     Abstract available


  332. NAKAZAWA T, Kikuchi M, Ishikawa M, Yamamori H, et al
    Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine.
    Schizophr Res. 2016 Oct 27. pii: S0920-9964(16)30456.
    PubMed     Text format     Abstract available


  333. DUNAYEVICH E, Buchanan RW, Chen CY, Yang J, et al
    Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.
    Schizophr Res. 2016 Oct 24. pii: S0920-9964(16)30471.
    PubMed     Text format     Abstract available


  334. MURRAY JD, Anticevic A
    Toward understanding thalamocortical dysfunction in schizophrenia through computational models of neural circuit dynamics.
    Schizophr Res. 2016 Oct 23. pii: S0920-9964(16)30465.
    PubMed     Text format     Abstract available


  335. KUNUTSOR SK, Laukkanen JA
    Serum gamma-glutamyltransferase is associated with future risk of psychosis - A prospective cohort study.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30469.
    PubMed     Text format    


  336. HUI L, Han M, Yin GZ, Zhang Y, et al
    Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30472.
    PubMed     Text format     Abstract available


  337. IVANOVA SA, Osmanova DZ, Boiko AS, Pozhidaev IV, et al
    Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30473.
    PubMed     Text format     Abstract available


  338. MUELLER TM, Yates SD, Haroutunian V, Meador-Woodruff JH, et al
    Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.
    Schizophr Res. 2016 Oct 20. pii: S0920-9964(16)30468.
    PubMed     Text format     Abstract available


  339. KOTLICKA-ANTCZAK M, Pawelczyk A, Karbownik MS, Pawelczyk T, et al
    Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis.
    Schizophr Res. 2016 Oct 17. pii: S0920-9964(16)30463.
    PubMed     Text format     Abstract available


  340. BULGARI V, Iozzino L, Ferrari C, Picchioni M, et al
    Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study.
    Schizophr Res. 2016 Oct 17. pii: S0920-9964(16)30460.
    PubMed     Text format     Abstract available


  341. KIM JH, Kim JH, Son YD, Joo YH, et al
    Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG.
    Schizophr Res. 2016 Oct 16. pii: S0920-9964(16)30464.
    PubMed     Text format     Abstract available


  342. CORDES J, Bechdolf A, Engelke C, Kahl KG, et al
    Prevalence of metabolic syndrome in female and male patients at risk of psychosis.
    Schizophr Res. 2016 Oct 14. pii: S0920-9964(16)30394.
    PubMed     Text format     Abstract available


  343. HARING L, Mottus R, Kajalaid K, Koch K, et al
    The course of cognitive functioning after first-episode of psychosis: A six month follow-up study.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30461.
    PubMed     Text format     Abstract available


  344. TULLY S, Wells A, Pyle M, Hudson J, et al
    Measuring common responses to psychosis: Assessing the psychometric properties of a new measure.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30459.
    PubMed     Text format     Abstract available


  345. RIDGEWELL C, Blackford JU, McHugo M, Heckers S, et al
    Personality traits predicting quality of life and overall functioning in schizophrenia.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30451.
    PubMed     Text format     Abstract available


  346. STEVENSON RA, Park S, Cochran C, McIntosh LG, et al
    The associations between multisensory temporal processing and symptoms of schizophrenia.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30444.
    PubMed     Text format     Abstract available


  347. GREENHALGH AM, Gonzalez-Blanco L, Garcia-Rizo C, Fernandez-Egea E, et al
    Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30435.
    PubMed     Text format     Abstract available


  348. DONDE C, Luck D, Grot S, Leitman DI, et al
    Tone-matching ability in patients with schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2016 Oct 11. pii: S0920-9964(16)30453.
    PubMed     Text format     Abstract available


  349. STARC M, Murray JD, Santamauro N, Savic A, et al
    Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition.
    Schizophr Res. 2016 Oct 10. pii: S0920-9964(16)30455.
    PubMed     Text format     Abstract available


  350. WINTON-BROWN TT, Elanjithara T, Power P, Coentre R, et al
    Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
    Schizophr Res. 2016 Oct 10. pii: S0920-9964(16)30437.
    PubMed     Text format     Abstract available


  351. SANCHEZ-TORRES AM, Elosua MR, Lorente-Omenaca R, Moreno-Izco L, et al
    Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis.
    Schizophr Res. 2016 Oct 9. pii: S0920-9964(16)30447.
    PubMed     Text format     Abstract available


  352. LANGE C, Deutschenbaur L, Borgwardt S, Lang UE, et al
    Experimentally induced psychosocial stress in schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2016 Oct 9. pii: S0920-9964(16)30452.
    PubMed     Text format     Abstract available


  353. BROSEY EA, Woodward ND
    Neuroanatomical correlates of perceptual aberrations in psychosis.
    Schizophr Res. 2016 Oct 8. pii: S0920-9964(16)30450.
    PubMed     Text format     Abstract available


  354. ZHAI D, Lang Y, Dong G, Liu Y, et al
    QTc interval lengthening in first-episode schizophrenia (FES) patients in the earliest stages of antipsychotic treatment.
    Schizophr Res. 2016 Oct 7. pii: S0920-9964(16)30449.
    PubMed     Text format     Abstract available


  355. KUANG C, Buchy L, Barbato M, Makowski C, et al
    A pilot study of cognitive insight and structural covariance in first-episode psychosis.
    Schizophr Res. 2016 Oct 6. pii: S0920-9964(16)30443.
    PubMed     Text format     Abstract available


  356. TARGUM SD, Risinger R, Du Y, Pendergrass JC, et al
    Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia.
    Schizophr Res. 2016 Oct 1. pii: S0920-9964(16)30442.
    PubMed     Text format     Abstract available


    September 2016
  357. FALKENBERG I, Valli I, Raffin M, Broome MR, et al
    Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosis.
    Schizophr Res. 2016 Sep 29. pii: S0920-9964(16)30431.
    PubMed     Text format     Abstract available


  358. CORNACCHIO D, Pinkham AE, Penn DL, Harvey PD, et al
    Self-assessment of social cognitive ability in individuals with schizophrenia: Appraising task difficulty and allocation of effort.
    Schizophr Res. 2016 Sep 29. pii: S0920-9964(16)30441.
    PubMed     Text format     Abstract available


  359. RAUTIO N, Miettunen J, Jaaskelainen E, Nordstrom T, et al
    Do adverse perinatal events predict mortality in schizophrenia during midlife?
    Schizophr Res. 2016 Sep 27. pii: S0920-9964(16)30439.
    PubMed     Text format     Abstract available


  360. SELLERS R, Varese F, Wells A, Morrison AP, et al
    A meta-analysis of metacognitive beliefs as implicated in the self-regulatory executive function model in clinical psychosis.
    Schizophr Res. 2016 Sep 23. pii: S0920-9964(16)30440.
    PubMed     Text format     Abstract available


  361. ROSENHECK R, Mueser KT, Sint K, Lin H, et al
    Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income.
    Schizophr Res. 2016 Sep 22. pii: S0920-9964(16)30432.
    PubMed     Text format     Abstract available


  362. HAHN LA, Mackinnon A, Dr DL, Winthrop VA, et al
    The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis.
    Schizophr Res. 2016 Sep 22. pii: S0920-9964(16)30436.
    PubMed     Text format     Abstract available


  363. MASSEY SH, Stern D, Alden EC, Petersen JE, et al
    Cortical thickness of neural substrates supporting cognitive empathy in individuals with schizophrenia.
    Schizophr Res. 2016 Sep 21. pii: S0920-9964(16)30433.
    PubMed     Text format     Abstract available


  364. NOEL JP, Cascio CJ, Wallace MT, Park S, et al
    The spatial self in schizophrenia and autism spectrum disorder.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30429.
    PubMed     Text format     Abstract available


  365. MOLINS C, Roldan A, Corripio I, Isohanni M, et al
    Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30424.
    PubMed     Text format    


  366. HONG S, Lee EE, Martin AS, Soontornniyomkij B, et al
    Abnormalities in chemokine levels in schizophrenia and their clinical correlates.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30427.
    PubMed     Text format     Abstract available


  367. RICHARD EA, Khlestova E, Nanu R, Lisman JE, et al
    Potential synergistic action of 19 schizophrenia risk genes in the thalamus.
    Schizophr Res. 2016 Sep 16. pii: S0920-9964(16)30390.
    PubMed     Text format     Abstract available


  368. ROCHE E, Lyne J, O'Donoghue B, Segurado R, et al
    The prognostic value of formal thought disorder following first episode psychosis.
    Schizophr Res. 2016 Sep 14. pii: S0920-9964(16)30425.
    PubMed     Text format     Abstract available


  369. CALDANI S, Bucci MP, Lamy JC, Seassau M, et al
    Saccadic eye movements as markers of schizophrenia spectrum: Exploration in at-risk mental states.
    Schizophr Res. 2016 Sep 14. pii: S0920-9964(16)30385.
    PubMed     Text format     Abstract available


  370. CHEN J, Calhoun VD, Pearlson GD, Perrone-Bizzozero NI, et al
    Independent component analysis of SNPs reflects polygenic risk scores for schizophrenia.
    Schizophr Res. 2016 Sep 13. pii: S0920-9964(16)30393.
    PubMed     Text format     Abstract available


  371. SAMALIN L, de Chazeron I, Blanc O, Brunel L, et al
    Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Schizophr Res. 2016 Sep 13. pii: S0920-9964(16)30419.
    PubMed     Text format     Abstract available


  372. LANDIN-ROMERO R, McKenna PJ, Romaguera A, Alvarez-Moya E, et al
    Examining the continuum of psychosis: Frequency and characteristics of psychotic-like symptoms in relatives and non-relatives of patients with schizophrenia.
    Schizophr Res. 2016 Sep 12. pii: S0920-9964(16)30330.
    PubMed     Text format     Abstract available


  373. DUSI N, Bellani M, Perlini C, Squarcina L, et al
    Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study.
    Schizophr Res. 2016 Sep 10. pii: S0920-9964(16)30395.
    PubMed     Text format     Abstract available


  374. FUJINO J, Hirose K, Tei S, Kawada R, et al
    Ambiguity aversion in schizophrenia: An fMRI study of decision-making under risk and ambiguity.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30388.
    PubMed     Text format     Abstract available


  375. DUNCAN MJ, Arbour-Nicitopoulos K, Subramanieapillai M, Remington G, et al
    Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing physical activity among individuals with schizophrenia.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30392.
    PubMed     Text format     Abstract available


  376. RAKHSHAN P, Sorensen H, DeVylder J, Mittal V, et al
    Childhood pegboard task predicts adult-onset psychosis-spectrum disorder among a genetic high-risk sample.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30367.
    PubMed     Text format     Abstract available


  377. POISSON A, Schluth Bolard C, Martin B, Babinet MN, et al
    16q12.2q21: A new susceptibility locus for schizophrenia?
    Schizophr Res. 2016 Sep 8. pii: S0920-9964(16)30389.
    PubMed     Text format    


  378. SANCHEZ-TORRES AM, Elosua MR, Lorente-Omenaca R, Moreno-Izco L, et al
    The Cognitive Assessment Interview: A comparative study in first episode and chronic patients with psychosis.
    Schizophr Res. 2016 Sep 8. pii: S0920-9964(16)30378.
    PubMed     Text format     Abstract available


  379. PEARSALL R, Gareze J, Park J, Walker A, et al
    Routine data linkage to identify and monitor diabetes in clozapine-treated patients with schizophrenia.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30375.
    PubMed     Text format    


  380. CAQUEO-URIZAR A, Fond G, Urzua A, Boyer L, et al
    Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30387.
    PubMed     Text format     Abstract available


  381. ZHAI D, Cui T, Xu Y, Feng Y, et al
    Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30383.
    PubMed     Text format     Abstract available


  382. SCHIMANSKI ID, Mouat KL, Billinghurst BL, Linscott RJ, et al
    Preliminary evidence that schizophrenia liability at age 15 predicts suicidal ideation two years later.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30380.
    PubMed     Text format     Abstract available


  383. BASLOW MH
    Is the tri-cellular N-acetylaspartylglutamate (NAAG) cycle related to the etiology of schizophrenia?
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30391.
    PubMed     Text format    


  384. ZAROGIANNI E, Storkey AJ, Johnstone EC, Owens DG, et al
    Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30377.
    PubMed     Text format     Abstract available


  385. RAZAFIMANDIMBY A, Herve PY, Marzloff V, Brazo P, et al
    Functional deficit of the medial prefrontal cortex during emotional sentence attribution in schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30386.
    PubMed     Text format     Abstract available


  386. COBIA DJ, Smith MJ, Salinas I, Ng C, et al
    Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30353.
    PubMed     Text format     Abstract available


  387. BRIDGMAN AC, Barr MS, Goodman MS, Zomorrodi R, et al
    Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30382.
    PubMed     Text format     Abstract available


  388. MISIAK B, Wisniewski J, Fleszar MG, Frydecka D, et al
    Alterations in l-arginine metabolism in first-episode schizophrenia patients: Further evidence for early metabolic dysregulation.
    Schizophr Res. 2016 Sep 5. pii: S0920-9964(16)30381.
    PubMed     Text format    


    August 2016
  389. MORITZ S, Balzan RP, Bohn F, Veckenstedt R, et al
    Subjective versus objective cognition: Evidence for poor metacognitive monitoring in schizophrenia.
    Schizophr Res. 2016 Aug 31. pii: S0920-9964(16)30371.
    PubMed     Text format     Abstract available


  390. CARNEY R, Yung AR, Amminger GP, Bradshaw T, et al
    Substance use in youth at risk for psychosis.
    Schizophr Res. 2016 Aug 30. pii: S0920-9964(16)30376.
    PubMed     Text format     Abstract available


  391. KIMURA H, Wang C, Ishizuka K, Xing J, et al
    Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30373.
    PubMed     Text format    


  392. DANDASH O, Pantelis C, Fornito A
    Dopamine, fronto-striato-thalamic circuits and risk for psychosis.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30370.
    PubMed     Text format     Abstract available


  393. VERMA D, Srivastava MK, Singh SK, Bhatia T, et al
    Lifetime suicide intent, executive function and insight in schizophrenia and schizoaffective disorders.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30359.
    PubMed     Text format    


  394. SERE L, Cardona D, Flichtentrei D, Lopez P, et al
    Schizophrenia: Is it time to rename it? The opinions of Latin American psychiatrists.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30369.
    PubMed     Text format    


  395. REDDY LF, Llerena K, Kern RS
    Predictors of employment in schizophrenia: The importance of intrinsic and extrinsic motivation.
    Schizophr Res. 2016 Aug 25. pii: S0920-9964(16)30356.
    PubMed     Text format     Abstract available


  396. BESTEHER B, Wagner G, Koch K, Schachtzabel C, et al
    Pronounced prefronto-temporal cortical thinning in schizophrenia: Neuroanatomical correlate of suicidal behavior?
    Schizophr Res. 2016 Aug 24. pii: S0920-9964(16)30360.
    PubMed     Text format     Abstract available


  397. DORPH-PETERSEN KA, Lewis DA
    Postmortem structural studies of the thalamus in schizophrenia.
    Schizophr Res. 2016 Aug 23. pii: S0920-9964(16)30357.
    PubMed     Text format     Abstract available


  398. CICERO DC, Klaunig MJ, Trask CL, Neis AM, et al
    Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophrenia.
    Schizophr Res. 2016 Aug 22. pii: S0920-9964(16)30368.
    PubMed     Text format     Abstract available


  399. LEE JS, Kim CY, Joo YH, Newell D, et al
    Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition.
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30361.
    PubMed     Text format     Abstract available


  400. LIEMBURG EJ, Bruins J, van Beveren N, Islam MA, et al
    Cannabis and a lower BMI in psychosis: What is the role of AKT1?
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30364.
    PubMed     Text format     Abstract available


  401. STAIN HJ, Bucci S, Baker AL, Carr V, et al
    A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30358.
    PubMed     Text format     Abstract available


  402. ADAMCZYK P, Daren A, Sulecka A, Bladzinski P, et al
    Do better communication skills promote sheltered employment in schizophrenia?
    Schizophr Res. 2016 Aug 18. pii: S0920-9964(16)30365.
    PubMed     Text format     Abstract available


  403. JEON DW, Shim JC, Kong BG, Moon JJ, et al
    Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial.
    Schizophr Res. 2016 Aug 16. pii: S0920-9964(16)30366.
    PubMed     Text format     Abstract available


  404. YOSHIDA K, Suzuki T, Imasaka Y, Kubo KI, et al
    Corrigendum to "resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan" [Schizophr. Res. Volume 171, Issues 1-3, March 2016, Pages 92-96].
    Schizophr Res. 2016 Aug 15. pii: S0920-9964(16)30363.
    PubMed     Text format    


  405. BROWN JS JR
    Cases of remission of psychosis following resection of pheochromocytoma or paraganglioma.
    Schizophr Res. 2016 Aug 14. pii: S0920-9964(16)30362.
    PubMed     Text format     Abstract available


  406. GIRALDO-CHICA M, Woodward ND
    Review of thalamocortical resting-state fMRI studies in schizophrenia.
    Schizophr Res. 2016 Aug 13. pii: S0920-9964(16)30355.
    PubMed     Text format     Abstract available


  407. MAMAH D, Musau A, Mutiso VN, Owoso A, et al
    Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents.
    Schizophr Res. 2016 Aug 10. pii: S0920-9964(16)30354.
    PubMed     Text format     Abstract available


  408. GOMES JS, Akiba H, Dias AM, Soares A, et al
    Trigeminal Nerve Stimulation for olfactory hallucinations in schizophrenia: case study.
    Schizophr Res. 2016 Aug 8. pii: S0920-9964(16)30352.
    PubMed     Text format    


  409. YOUNG A, Wimmer RD
    Implications for the thalamic reticular nucleus in impaired attention and sleep in schizophrenia.
    Schizophr Res. 2016 Aug 7. pii: S0920-9964(16)30327.
    PubMed     Text format     Abstract available


  410. HAIGH SM, Coffman BA, Murphy TK, Butera CD, et al
    Abnormal auditory pattern perception in schizophrenia.
    Schizophr Res. 2016 Aug 5. pii: S0920-9964(16)30323.
    PubMed     Text format     Abstract available


  411. WILLI TS, Lang DJ, Honer WG, Smith GN, et al
    Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Schizophr Res. 2016 Aug 4. pii: S0920-9964(16)30351.
    PubMed     Text format     Abstract available


  412. DRUCAROFF LJ, Costanzo EY, Castro MN, Ortiz-Villafane M, et al
    Hemispheric specialization of mood processing is abnormal in patients with schizophrenia.
    Schizophr Res. 2016 Aug 1. pii: S0920-9964(16)30350.
    PubMed     Text format    


    July 2016
  413. LI X, Thermenos HW, Wu Z, Momura Y, et al
    Abnormal interactions of verbal- and spatial-memory networks in young people at familial high-risk for schizophrenia.
    Schizophr Res. 2016 Jul 29. pii: S0920-9964(16)30348.
    PubMed     Text format     Abstract available


  414. PETRWINKLER, Mlada K, Krupchanka D, Agius M, et al
    Corrigendum to "Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012" (Schizophr. Res. vol. 175, issues 1-3, August 2016, pages 180-185).
    Schizophr Res. 2016 Jul 28. pii: S0920-9964(16)30347.
    PubMed     Text format    


  415. HALLFORD P, Clair DS, Halley L, Mustard C, et al
    A study of type-1 diabetes associated autoantibodies in schizophrenia.
    Schizophr Res. 2016 Jul 26. pii: S0920-9964(16)30346.
    PubMed     Text format     Abstract available


  416. CHUANG YA, Hu TM, Chen CH, Hsu SH, et al
    Rare mutations and hypermethylation of the ARC gene associated with schizophrenia.
    Schizophr Res. 2016 Jul 24. pii: S0920-9964(16)30345.
    PubMed     Text format     Abstract available


  417. SANTELMANN H, Franklin J, Busshoff J, Baethge C, et al
    Interrater reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression - A systematic review and meta-analysis.
    Schizophr Res. 2016 Jul 22. pii: S0920-9964(16)30328.
    PubMed     Text format     Abstract available


  418. KITTIPEERACHON M, Chaichan W
    Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
    Schizophr Res. 2016 Jul 22. pii: S0920-9964(16)30333.
    PubMed     Text format     Abstract available


  419. VAN DEN BERG DP, van der Vleugel BM, de Bont PA, Staring AB, et al
    Predicting trauma-focused treatment outcome in psychosis.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30332.
    PubMed     Text format     Abstract available


  420. PERGOLA G, Trizio S, Di Carlo P, Taurisano P, et al
    Grey matter volume patterns in thalamic nuclei are associated with familial risk for schizophrenia.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30321.
    PubMed     Text format     Abstract available


  421. SADOWSKA-BARTOSZ I, Galiniak S, Bartosz G, Zuberek M, et al
    Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30326.
    PubMed     Text format     Abstract available


  422. HESS JL, Tylee DS, Barve R, de Jong S, et al
    Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.
    Schizophr Res. 2016 Jul 19. pii: S0920-9964(16)30322.
    PubMed     Text format     Abstract available


  423. BORNHEIMER LA
    Moderating effects of positive symptoms of psychosis in suicidal ideation among adults diagnosed with schizophrenia.
    Schizophr Res. 2016 Jul 19. pii: S0920-9964(16)30325.
    PubMed     Text format     Abstract available


  424. MCCLEERY A, Lee J, Fiske AP, Ghermezi L, et al
    Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.
    Schizophr Res. 2016 Jul 18. pii: S0920-9964(16)30324.
    PubMed     Text format     Abstract available


  425. DURGAM S, Earley W, Li R, Li D, et al
    Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Schizophr Res. 2016 Jul 14. pii: S0920-9964(16)30312.
    PubMed     Text format     Abstract available


  426. SHIM M, Hwang HJ, Kim DW, Lee SH, et al
    Machine-learning-based diagnosis of schizophrenia using combined sensor-level and source-level EEG features.
    Schizophr Res. 2016 Jul 14. pii: S0920-9964(16)30227.
    PubMed     Text format     Abstract available


  427. WOOD L, Burke E, Byrne R, Enache G, et al
    Semi-structured Interview Measure of Stigma (SIMS) in psychosis: Assessment of psychometric properties.
    Schizophr Res. 2016 Jul 13. pii: S0920-9964(16)30275.
    PubMed     Text format     Abstract available


  428. ZENI-GRAIFF M, Rizzo LB, Mansur RB, Maurya PK, et al
    Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.
    Schizophr Res. 2016 Jul 13. pii: S0920-9964(16)30313.
    PubMed     Text format     Abstract available


  429. CELLA M, Edwards C, Wykes T
    A question of time: A study of time use in people with schizophrenia.
    Schizophr Res. 2016 Jul 12. pii: S0920-9964(16)30315.
    PubMed     Text format     Abstract available


  430. LEVINE SZ, Levav I, Pugachova I, Yoffe R, et al
    Transgenerational effects of genocide exposure on the risk and course of schizophrenia: A population-based study.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30286.
    PubMed     Text format     Abstract available


  431. GUAN F, Zhang T, Li L, Fu D, et al
    Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30320.
    PubMed     Text format     Abstract available


  432. WOMER FY, Tang Y, Harms MP, Bai C, et al
    Sexual dimorphism of the cerebellar vermis in schizophrenia.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30310.
    PubMed     Text format     Abstract available


  433. DOLLFUS S, Lyne J
    Negative symptoms: History of the concept and their position in diagnosis of schizophrenia.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30291.
    PubMed     Text format    


  434. MORRA LF, Strauss GP
    Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.
    Schizophr Res. 2016 Jul 7. pii: S0920-9964(16)30317.
    PubMed     Text format     Abstract available


  435. SAWA A, Sedlak TW
    Oxidative stress and inflammation in schizophrenia.
    Schizophr Res. 2016 Jul 6. pii: S0920-9964(16)30281.
    PubMed     Text format    


  436. ZHANG B, Deng L, Wu H, Lu X, et al
    Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and beta-CrossLaps.
    Schizophr Res. 2016 Jul 2. pii: S0920-9964(16)30316.
    PubMed     Text format     Abstract available


    June 2016
  437. GURURAJAN A, Malone DT
    Does cannabidiol have a role in the treatment of schizophrenia?
    Schizophr Res. 2016 Jun 30. pii: S0920-9964(16)30289.
    PubMed     Text format     Abstract available


  438. FALKAI P, Schmitt A
    News from the graveyard: Neuropathological research on schizophrenia is alive and productive.
    Schizophr Res. 2016 Jun 29. pii: S0920-9964(16)30311.
    PubMed     Text format    


  439. GOGHARI VM, Harrow M
    Twenty year multi-follow-up of different types of hallucinations in schizophrenia, schizoaffective disorder, bipolar disorder, and depression.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30309.
    PubMed     Text format     Abstract available


  440. GRENT-'T-JONG T, Rivolta D, Sauer A, Grube M, et al
    MEG-measured visually induced gamma-band oscillations in chronic schizophrenia: Evidence for impaired generation of rhythmic activity in ventral stream regions.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30270.
    PubMed     Text format     Abstract available


  441. LIM A, Hoek HW, Deen ML, Blom JD, et al
    Prevalence and classification of hallucinations in multiple sensory modalities in schizophrenia spectrum disorders.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30277.
    PubMed     Text format     Abstract available


  442. MICHAEL J, Park S
    Anomalous bodily experiences and perceived social isolation in schizophrenia: An extension of the Social Deafferentation Hypothesis.
    Schizophr Res. 2016 Jun 23. pii: S0920-9964(16)30280.
    PubMed     Text format     Abstract available


  443. ON ZX, Cotton S, Farhall J, Killackey E, et al
    Relationship between duration of untreated psychosis and neurocognition and social cognition in first-episode psychosis.
    Schizophr Res. 2016 Jun 23. pii: S0920-9964(16)30285.
    PubMed     Text format     Abstract available


  444. KIRKBRIDE JB, Perez J, Jones PB
    Neighbourhood communalities and ultra-high risk psychosis: An emergent literature.
    Schizophr Res. 2016 Jun 22. pii: S0920-9964(16)30288.
    PubMed     Text format    


  445. KEANE BP, Silverstein SM, Wang Y, Roche MW, et al
    Seeing more clearly through psychosis: Depth inversion illusions are normal in bipolar disorder but reduced in schizophrenia.
    Schizophr Res. 2016 Jun 22. pii: S0920-9964(16)30282.
    PubMed     Text format     Abstract available


  446. KUHL JO, Laursen TM, Thorup A, Nordentoft M, et al
    The incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000-2012. A register-based study.
    Schizophr Res. 2016 Jun 21. pii: S0920-9964(16)30290.
    PubMed     Text format     Abstract available


  447. SANTOS CM, Peres FF, Diana MC, Justi V, et al
    Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model.
    Schizophr Res. 2016 Jun 21. pii: S0920-9964(16)30273.
    PubMed     Text format     Abstract available


  448. EDWARDS AC, Bacanu SA, Bigdeli TB, Moscati A, et al
    Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study.
    Schizophr Res. 2016 Jun 20. pii: S0920-9964(16)30283.
    PubMed     Text format     Abstract available


  449. COX DA, Gottschalk MG, Wesseling H, Ernst A, et al
    Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
    Schizophr Res. 2016 Jun 19. pii: S0920-9964(16)30279.
    PubMed     Text format     Abstract available


  450. SAVILL M, Orfanos S, Reininghaus U, Wykes T, et al
    The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia.
    Schizophr Res. 2016 Jun 18. pii: S0920-9964(16)30284.
    PubMed     Text format     Abstract available


  451. SALLMEN M, Suvisaari J, Lindbohm ML, Malaspina D, et al
    Paternal occupational lead exposure and offspring risks for schizophrenia.
    Schizophr Res. 2016 Jun 15. pii: S0920-9964(16)30271.
    PubMed     Text format     Abstract available


  452. LEE EE, Eyler LT, Wolkowitz OM, Martin AS, et al
    Elevated plasma F2-isoprostane levels in schizophrenia.
    Schizophr Res. 2016 Jun 15. pii: S0920-9964(16)30278.
    PubMed     Text format     Abstract available


  453. BORA E, Veznedaroglu B, Vahip S
    Theory of mind and executive functions in schizophrenia and bipolar disorder: A cross-diagnostic latent class analysis for identification of neuropsychological subtypes.
    Schizophr Res. 2016 Jun 14. pii: S0920-9964(16)30274.
    PubMed     Text format     Abstract available


  454. RAFFARD S, Bortolon C, Khoramshahi M, Salesse RN, et al
    Humanoid robots versus humans: How is emotional valence of facial expressions recognized by individuals with schizophrenia? An exploratory study.
    Schizophr Res. 2016 Jun 9. pii: S0920-9964(16)30268.
    PubMed     Text format     Abstract available


  455. IWASHIRO N, Koike S, Satomura Y, Suga M, et al
    Letter to the editor; A corrigendum with respect to our research article entitled "Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: A multi-modal neuroimaging
    Schizophr Res. 2016 Jun 6. pii: S0920-9964(16)30267.
    PubMed     Text format    


  456. FERRARELLI F, Tononi G
    Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia.
    Schizophr Res. 2016 Jun 3. pii: S0920-9964(16)30247.
    PubMed     Text format     Abstract available


  457. ALVARADO-ALANIS P, Leon-Ortiz P, Reyes-Madrigal F, Favila R, et al
    Corrigendum to "abnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].
    Schizophr Res. 2016 Jun 2. pii: S0920-9964(16)30249.
    PubMed     Text format    


  458. RANDALL JR, Chateau D, Smith M, Taylor C, et al
    An early intervention for psychosis and its effect on criminal accusations and suicidal behaviour using a matched-cohort design.
    Schizophr Res. 2016 Jun 1. pii: S0920-9964(16)30244.
    PubMed     Text format     Abstract available


  459. DICKERSON F, Adamos MB, Katsafanas E, Khushalani S, et al
    The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Schizophr Res. 2016 Jun 1. pii: S0920-9964(16)30246.
    PubMed     Text format     Abstract available


    May 2016
  460. STUBBS B, Firth J, Berry A, Schuch FB, et al
    How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression.
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30241.
    PubMed     Text format     Abstract available


  461. PERALTA V, Cuesta MJ
    Characteristics and clinical correlates of dimensions of delusional experience in schizophrenia and delusional disorder.
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30248.
    PubMed     Text format    


  462. TAKEUCHI H, Fervaha G, Lee J, Remington G, et al
    What symptom domains are associated with patient distress in schizophrenia?
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30245.
    PubMed     Text format    


  463. WOOD L, Byrne R, Varese F, Morrison AP, et al
    Psychosocial interventions for internalised stigma in people with a schizophrenia-spectrum diagnosis: A systematic narrative synthesis and meta-analysis.
    Schizophr Res. 2016 May 30. pii: S0920-9964(16)30219.
    PubMed     Text format     Abstract available


  464. DE DEYNE S, Elvevag B, Hui CL, Poon VW, et al
    Rich semantic networks applied to schizophrenia: A new framework.
    Schizophr Res. 2016 May 28. pii: S0920-9964(16)30240.
    PubMed     Text format    


  465. REDDY LF, Green MF, Wynn JK, Rinck M, et al
    Approaching anger in schizophrenia: What an implicit task tells you that self-report does not.
    Schizophr Res. 2016 May 27. pii: S0920-9964(16)30242.
    PubMed     Text format     Abstract available


  466. MCFADDEN WC, Jaffe AE, Ye T, Paltan-Ortiz JD, et al
    Assessment of genetic risk for distribution of total interstitial white matter neurons in dorsolateral prefrontal cortex: role in schizophrenia.
    Schizophr Res. 2016 May 27. pii: S0920-9964(16)30156.
    PubMed     Text format    


  467. FU YY, Zhang T, Xiu MH, Tang W, et al
    Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.
    Schizophr Res. 2016 May 26. pii: S0920-9964(16)30232.
    PubMed     Text format     Abstract available


  468. PINACHO R, Villalmanzo N, Meana JJ, Ferrer I, et al
    Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30220.
    PubMed     Text format     Abstract available


  469. HASSAN AN, Stuart EA, De Luca V
    Childhood maltreatment increases the risk of suicide attempt in schizophrenia.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30236.
    PubMed     Text format     Abstract available


  470. HESLIN M, Lappin JM, Donoghue K, Lomas B, et al
    Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30198.
    PubMed     Text format     Abstract available


  471. FOTI D, Perlman G, Hajcak G, Mohanty A, et al
    Impaired error processing in late-phase psychosis: Four-year stability and relationships with negative symptoms.
    Schizophr Res. 2016 May 24. pii: S0920-9964(16)30230.
    PubMed     Text format     Abstract available


  472. SEOW LS, Ong C, Mahesh MV, Sagayadevan V, et al
    A systematic review on comorbid post-traumatic stress disorder in schizophrenia.
    Schizophr Res. 2016 May 23. pii: S0920-9964(16)30225.
    PubMed     Text format     Abstract available


  473. SAPRA M, Lawson D, Iranmanesh A, Varma A, et al
    Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics.
    Schizophr Res. 2016 May 19. pii: S0920-9964(16)30221.
    PubMed     Text format     Abstract available


  474. GALDERISI S, Rossi A, Rocca P, Bertolino A, et al
    Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30189.
    PubMed     Text format     Abstract available


  475. CELIK C, Balikci A, Ozdemir B, Oznur T, et al
    BDNF and other biological markers are associated with schizophrenia onset and positive symptoms: A different approach.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30226.
    PubMed     Text format    


  476. BAUDIN G, Godin O, Lajnef M, Aouizerate B, et al
    Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30190.
    PubMed     Text format     Abstract available


  477. MORITZ S, Ludtke T, Westermann S, Hermeneit J, et al
    Dysfunctional coping with stress in psychosis. An investigation with the Maladaptive and Adaptive Coping Styles (MAX) questionnaire.
    Schizophr Res. 2016 May 17. pii: S0920-9964(16)30174.
    PubMed     Text format     Abstract available


  478. MORITZ S, Schroder J, Klein JP, Lincoln TM, et al
    Effects of online intervention for depression on mood and positive symptoms in schizophrenia.
    Schizophr Res. 2016 May 17. pii: S0920-9964(16)30182.
    PubMed     Text format     Abstract available


  479. HOU CL, Xiang YT, Wang ZL, Everall I, et al
    Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Schizophr Res. 2016 May 16. pii: S0920-9964(16)30183.
    PubMed     Text format     Abstract available


  480. ROMINGER C, Bleier A, Fitz W, Marksteiner J, et al
    Auditory top-down control and affective theory of mind in schizophrenia with and without hallucinations.
    Schizophr Res. 2016 May 16. pii: S0920-9964(16)30228.
    PubMed     Text format     Abstract available


  481. KANE JM, Skuban A, Hobart M, Ouyang J, et al
    Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.
    Schizophr Res. 2016 May 14. pii: S0920-9964(16)30162.
    PubMed     Text format     Abstract available


  482. MIZUNO Y, Hofer A, Suzuki T, Frajo-Apor B, et al
    Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study.
    Schizophr Res. 2016 May 13. pii: S0920-9964(16)30196.
    PubMed     Text format     Abstract available


  483. GALDERISI S, Farden A, Kaiser S
    Dissecting negative symptoms of schizophrenia: History, assessment, pathophysiological mechanisms and treatment.
    Schizophr Res. 2016 May 13. pii: S0920-9964(16)30195.
    PubMed     Text format    


  484. DEAN B, Copolov D, Scarr E
    Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank.
    Schizophr Res. 2016 May 12. pii: S0920-9964(16)30186.
    PubMed     Text format     Abstract available


  485. BARKER V, Bois C, Neilson E, Johnstone EC, et al
    Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.
    Schizophr Res. 2016 May 11. pii: S0920-9964(16)30177.
    PubMed     Text format     Abstract available


  486. CERETTA AP, Schaffer LF, de Freitas CM, Reinheimer JB, et al
    Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia.
    Schizophr Res. 2016 May 11. pii: S0920-9964(16)30193.
    PubMed     Text format    


  487. ALBACETE A, Bosque C, Custal N, Crespo JM, et al
    Emotional intelligence in non-psychotic first-degree relatives of people with schizophrenia.
    Schizophr Res. 2016 May 10. pii: S0920-9964(16)30188.
    PubMed     Text format     Abstract available


  488. AOKI A, Aoki Y, Goulden R, Kasai K, et al
    Change in newspaper coverage of schizophrenia in Japan over 20-year period.
    Schizophr Res. 2016 May 10. pii: S0920-9964(16)30175.
    PubMed     Text format     Abstract available


  489. NELSON B, Yuen HP, Lin A, Wood SJ, et al
    Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention.
    Schizophr Res. 2016 May 9. pii: S0920-9964(16)30191.
    PubMed     Text format     Abstract available


  490. DEIGHTON S, Buchy L, Cadenhead KS, Cannon TD, et al
    Traumatic brain injury in individuals at clinical high risk for psychosis.
    Schizophr Res. 2016 May 7. pii: S0920-9964(16)30192.
    PubMed     Text format     Abstract available


  491. KINDLER J, Schultze-Lutter F, Michel C, Martz-Irngartinger A, et al
    Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study.
    Schizophr Res. 2016 May 7. pii: S0920-9964(16)30181.
    PubMed     Text format     Abstract available


  492. PACCALET T, Gilbert E, Berthelot N, Marquet P, et al
    Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder.
    Schizophr Res. 2016 May 6. pii: S0920-9964(16)30187.
    PubMed     Text format    


  493. BERNIER D, Bartha R, McAllindon D, Hanstock CC, et al
    Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla H-MRS study.
    Schizophr Res. 2016 May 5. pii: S0920-9964(16)30172.
    PubMed     Text format     Abstract available


  494. KOYANAGI A, Stickley A, Haro JM
    Subclinical psychosis and pain in an English national sample: The role of common mental disorders.
    Schizophr Res. 2016 May 5. pii: S0920-9964(16)30180.
    PubMed     Text format     Abstract available


  495. PINACHO R, Vila E, Prades R, Tarrago T, et al
    The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia.
    Schizophr Res. 2016 May 4. pii: S0920-9964(16)30169.
    PubMed     Text format     Abstract available


  496. MILLER BJ, Goldsmith DR, Paletta N, Wong J, et al
    Parental type 2 diabetes in patients with non-affective psychosis.
    Schizophr Res. 2016 May 4. pii: S0920-9964(16)30184.
    PubMed     Text format     Abstract available


  497. MALLA A, Mustafa S, Rho A, Abadi S, et al
    Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Schizophr Res. 2016 May 3. pii: S0920-9964(16)30185.
    PubMed     Text format     Abstract available


  498. CORRELL CU, Skuban A, Hobart M, Ouyang J, et al
    Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies.
    Schizophr Res. 2016 May 3. pii: S0920-9964(16)30161.
    PubMed     Text format     Abstract available


  499. VIKHREVA OV, Rakhmanova VI, Orlovskaya DD, Uranova NA, et al
    Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study.
    Schizophr Res. 2016 May 2. pii: S0920-9964(16)30173.
    PubMed     Text format     Abstract available


  500. PAKSARIAN D, Merikangas KR, Calkins ME, Gur RE, et al
    Erratum to "Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a U.S. sample of youths" [Schizophr. Res. 170 (2016) 205-210].
    Schizophr Res. 2016;173.
    PubMed     Text format    


    April 2016
  501. DUNN W, Rassovsky Y, Wynn JK, Wu AD, et al
    Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30171.
    PubMed     Text format     Abstract available


  502. MILLARD SP, Shofer J, Braff D, Calkins M, et al
    Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30160.
    PubMed     Text format     Abstract available


  503. JOHANSSON AS, Owe-Larsson B, Hetta J, Lundkvist GB, et al
    Altered circadian clock gene expression in patients with schizophrenia.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30178.
    PubMed     Text format     Abstract available


  504. GEE B, Hodgekins J, Fowler D, Marshall M, et al
    The course of negative symptom in first episode psychosis and the relationship with social recovery.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30166.
    PubMed     Text format     Abstract available


  505. CZEPIELEWSKI LS, Massuda R, Panizzutti B, da Rosa ED, et al
    Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging.
    Schizophr Res. 2016 Apr 27. pii: S0920-9964(16)30135.
    PubMed     Text format     Abstract available


  506. STEPHAN-OTTO C, Siddi S, Cuevas Esteban J, Senior C, et al
    Neural activity during object perception in schizophrenia patients is associated with illness duration and affective symptoms.
    Schizophr Res. 2016 Apr 26. pii: S0920-9964(16)30170.
    PubMed     Text format     Abstract available


  507. GARCIA-BEA A, Walker MA, Hyde TM, Kleinman JE, et al
    Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
    Schizophr Res. 2016 Apr 26. pii: S0920-9964(16)30164.
    PubMed     Text format     Abstract available


  508. CASEY D, Brown L, Galwani R, Islam Z, et al
    Predictors of engagement in first-episode psychosis.
    Schizophr Res. 2016 Apr 25. pii: S0920-9964(16)30179.
    PubMed     Text format     Abstract available


  509. UHRIG S, Hirth N, Broccoli L, von Wilmsdorff M, et al
    Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study.
    Schizophr Res. 2016 Apr 25. pii: S0920-9964(16)30168.
    PubMed     Text format     Abstract available


  510. BORA E, Pantelis C
    Social cognition in schizophrenia in comparison to bipolar disorder: A meta-analysis.
    Schizophr Res. 2016 Apr 22. pii: S0920-9964(16)30167.
    PubMed     Text format     Abstract available


  511. HUBER CG, Hochstrasser L, Meister K, Schimmelmann BG, et al
    Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder.
    Schizophr Res. 2016 Apr 22. pii: S0920-9964(16)30176.
    PubMed     Text format     Abstract available


  512. KLINE E, Millman ZB, Denenny D, Wilson C, et al
    Trauma and psychosis symptoms in a sample of help-seeking youth.
    Schizophr Res. 2016 Apr 20. pii: S0920-9964(16)30155.
    PubMed     Text format     Abstract available


  513. JOHN J, Bhatia T, Kukshal P, Chandna P, et al
    Association study of MiRSNPs with schizophrenia, tardive dyskinesia and cognition.
    Schizophr Res. 2016 Apr 19. pii: S0920-9964(16)30123.
    PubMed     Text format     Abstract available


  514. VERU F, Jordan G, Joober R, Malla A, et al
    Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Schizophr Res. 2016 Apr 18. pii: S0920-9964(16)30127.
    PubMed     Text format     Abstract available


  515. VOGEL T, Smieskova R, Schmidt A, Walter A, et al
    Increased superior frontal gyrus activation during working memory processing in psychosis: Significant relation to cumulative antipsychotic medication and to negative symptoms.
    Schizophr Res. 2016 Apr 18. pii: S0920-9964(16)30125.
    PubMed     Text format     Abstract available


  516. OHI K, Kikuchi M, Ikeda M, Yamamori H, et al
    Polygenetic components for schizophrenia, bipolar disorder and rheumatoid arthritis predict risk of schizophrenia.
    Schizophr Res. 2016 Apr 17. pii: S0920-9964(16)30158.
    PubMed     Text format    


  517. SAIA-CEREDA VM, Cassoli JS, Schmitt A, Falkai P, et al
    Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30114.
    PubMed     Text format     Abstract available


  518. VAN HAREN NE, Kahn RS
    Progressive brain tissue loss in schizophrenia.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30115.
    PubMed     Text format    


  519. WINKLER P, Mlada K, Krupchanka D, Agius M, et al
    Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30157.
    PubMed     Text format     Abstract available


  520. VITA A, Deste G, Barlati S, Grano A, et al
    Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia?
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30126.
    PubMed     Text format     Abstract available


  521. BONFILS KA, Lysaker PH, Minor KS, Salyers MP, et al
    Affective empathy in schizophrenia: a meta-analysis.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30129.
    PubMed     Text format     Abstract available


  522. WANG MY, Ho NF, Sum MY, Collinson SL, et al
    Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Schizophr Res. 2016 Apr 14. pii: S0920-9964(16)30134.
    PubMed     Text format     Abstract available


  523. MAVROGIORGOU P, Dunnweber M, Juckel G
    Obsessive compulsive symptoms (OCS) in patients with schizophrenia are rare.
    Schizophr Res. 2016 Apr 13. pii: S0920-9964(16)30132.
    PubMed     Text format    


  524. HAIGH SM, Gupta A, Barb SM, Glass SA, et al
    Differential sensory fMRI signatures in autism and schizophrenia: Analysis of amplitude and trial-to-trial variability.
    Schizophr Res. 2016 Apr 12. pii: S0920-9964(16)30128.
    PubMed     Text format     Abstract available


  525. BJORKQUIST OA, Olsen EK, Nelson BD, Herbener ES, et al
    Altered amygdala-prefrontal connectivity during emotion perception in schizophrenia.
    Schizophr Res. 2016 Apr 12. pii: S0920-9964(16)30136.
    PubMed     Text format     Abstract available


  526. WIMBERLEY T, Pedersen CB, MacCabe JH, Stovring H, et al
    Inverse association between urbanicity and treatment resistance in schizophrenia.
    Schizophr Res. 2016 Apr 8. pii: S0920-9964(16)30113.
    PubMed     Text format     Abstract available


  527. GONZALEZ-PENAS J, Amigo J, Santome L, Sobrino B, et al
    Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states.
    Schizophr Res. 2016 Apr 8. pii: S0920-9964(16)30121.
    PubMed     Text format     Abstract available


  528. ISITT JJ, Nadipelli VR, Kouassi A, Fava M, et al
    Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study.
    Schizophr Res. 2016 Apr 7. pii: S0920-9964(16)30105.
    PubMed     Text format     Abstract available


  529. OHI K, Shimada T, Nitta Y, Kihara H, et al
    Specific gene expression patterns of 108 schizophrenia-associated loci in cortex.
    Schizophr Res. 2016 Apr 6. pii: S0920-9964(16)30124.
    PubMed     Text format     Abstract available


  530. CHOU PH, Chu CS, Lin CH, Cheng C, et al
    Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.
    Schizophr Res. 2016 Apr 6. pii: S0920-9964(16)30120.
    PubMed     Text format     Abstract available


  531. GONZALEZ-BLANCO L, Greenhalgh AM, Garcia-Rizo C, Egea EF, et al
    Prolactin concentrations in antipsychotic-naive patients with schizophrenia and related disorders: A meta-analysis.
    Schizophr Res. 2016 Apr 5. pii: S0920-9964(16)30111.
    PubMed     Text format     Abstract available


  532. SHIN YS, Kim SY, Lee TY, Hur JW, et al
    Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2016 Apr 5. pii: S0920-9964(16)30116.
    PubMed     Text format     Abstract available


  533. ONWUAMEZE OE, Titone D, Ho BC
    Transitive inference deficits in unaffected biological relatives of schizophrenia patients.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30071.
    PubMed     Text format     Abstract available


  534. HUI CL, Poon VW, Ko WT, Miao HY, et al
    Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30118.
    PubMed     Text format     Abstract available


  535. BERGH S, Hjorthoj C, Sorensen HJ, Fagerlund B, et al
    Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30117.
    PubMed     Text format     Abstract available


  536. NIEMAN DH, Dragt S, van Duin ED, Denneman N, et al
    COMT ValMet genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Schizophr Res. 2016 Apr 1. pii: S0920-9964(16)30108.
    PubMed     Text format     Abstract available


  537. GREENWOOD KE, Morris R, Smith V, Jones AM, et al
    Virtual shopping: A viable alternative to direct assessment of real life function?
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


  538. BLANCO-LOPEZ MJ, Cudeiro-Blanco J, Iglesias G, Gago A, et al
    A simple, repeated rTMS protocol effectively removes auditory verbal hallucinations in a single patient study.
    Schizophr Res. 2016;172.
    PubMed     Text format    


  539. STONE WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, et al
    Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


  540. DE SOUSA P, Sellwood W, Spray A, Bentall RP, et al
    The affective reactivity of psychotic speech: The role of internal source monitoring in explaining increased thought disorder under emotional challenge.
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


    March 2016
  541. COFFMAN BA, Haigh SM, Murphy TK, Salisbury DF, et al
    Event-related potentials demonstrate deficits in acoustic segmentation in schizophrenia.
    Schizophr Res. 2016 Mar 28. pii: S0920-9964(16)30103.
    PubMed     Text format     Abstract available


  542. SHUKLA AA, Jha M, Birchfield T, Mukherjee S, et al
    COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Schizophr Res. 2016 Mar 24. pii: S0920-9964(16)30112.
    PubMed     Text format     Abstract available


  543. WRIGHT B, Peters E, Ettinger U, Kuipers E, et al
    Effects of environmental noise on cognitive (dys)functions in schizophrenia: A pilot within-subjects experimental study.
    Schizophr Res. 2016 Mar 23. pii: S0920-9964(16)30110.
    PubMed     Text format     Abstract available


  544. CHANG WC, Kwong VW, Chan GH, Jim OT, et al
    Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong.
    Schizophr Res. 2016 Mar 23. pii: S0920-9964(16)30109.
    PubMed     Text format     Abstract available


  545. ANTONUCCI LA, Taurisano P, Fazio L, Gelao B, et al
    Association of familial risk for schizophrenia with thalamic and medial prefrontal functional connectivity during attentional control.
    Schizophr Res. 2016 Mar 21. pii: S0920-9964(16)30107.
    PubMed     Text format     Abstract available


  546. POTVIN S, Lungu O, Lipp O, Lalonde P, et al
    Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings.
    Schizophr Res. 2016 Mar 18. pii: S0920-9964(16)30104.
    PubMed     Text format     Abstract available


  547. OMER S, Finnegan M, Pringle DG, Kinsella A, et al
    Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Schizophr Res. 2016 Mar 17. pii: S0920-9964(16)30098.
    PubMed     Text format     Abstract available


  548. CUI LB, Liu K, Li C, Wang LX, et al
    Putamen-related regional and network functional deficits in first-episode schizophrenia with auditory verbal hallucinations.
    Schizophr Res. 2016 Mar 16. pii: S0920-9964(16)30093.
    PubMed     Text format     Abstract available


  549. WU CS, Cheng IC, Feng J, Chen CL, et al
    Comparison of treatment effectiveness and medical costs for different long-acting injectable antipsychotics in patients with schizophrenia in Taiwan: A nationwide population-based cohort study.
    Schizophr Res. 2016 Mar 14. pii: S0920-9964(16)30091.
    PubMed     Text format     Abstract available


  550. ARMSTRONG HF, Bartels MN, Paslavski O, Cain D, et al
    The impact of aerobic exercise training on cardiopulmonary functioning in individuals with schizophrenia.
    Schizophr Res. 2016 Mar 11. pii: S0920-9964(16)30102.
    PubMed     Text format    


  551. VOLK DW, Edelson JR, Lewis DA
    Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 Mar 10. pii: S0920-9964(16)30094.
    PubMed     Text format     Abstract available


  552. RAUTIO N, Kakela J, Nordstrom T, Miettunen J, et al
    Prognosis of schizophrenia spectrum disorder may not be predetermined during early development - the Northern Finland Birth Cohort 1966.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30092.
    PubMed     Text format     Abstract available


  553. KANAHARA N, Kimura H, Iyo M
    Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia".
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30099.
    PubMed     Text format    


  554. BARAKAUSKAS VE, Moradian A, Barr AM, Beasley CL, et al
    Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30095.
    PubMed     Text format     Abstract available


  555. NAEEM F, Johal R, McKenna C, Rathod S, et al
    Cognitive Behavior Therapy for psychosis based Guided Self-help (CBTp-GSH) delivered by frontline mental health professionals: Results of a feasibility study.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30096.
    PubMed     Text format     Abstract available


  556. TARRICONE I, Boydell J, Kokona A, Triolo F, et al
    Risk of psychosis and internal migration: Results from the Bologna First Episode Psychosis study.
    Schizophr Res. 2016 Mar 8. pii: S0920-9964(16)30088.
    PubMed     Text format     Abstract available


  557. THERMENOS HW, Juelich RJ, DiChiara SR, Mesholam-Gately RI, et al
    Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Schizophr Res. 2016 Mar 7. pii: S0920-9964(16)30078.
    PubMed     Text format     Abstract available


  558. BERNSTEIN HG, Hildebrandt J, Dobrowolny H, Steiner J, et al
    Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula.
    Schizophr Res. 2016 Mar 3. pii: S0920-9964(16)30090.
    PubMed     Text format     Abstract available


  559. DEPP CA, Moore RC, Perivoliotis D, Holden JL, et al
    Social behavior, interaction appraisals, and suicidal ideation in schizophrenia: The dangers of being alone.
    Schizophr Res. 2016 Mar 2. pii: S0920-9964(16)30083.
    PubMed     Text format     Abstract available


  560. DAVIDSON CA, Johannesen JK, Fiszdon JM
    Role of learning potential in cognitive remediation: Construct and predictive validity.
    Schizophr Res. 2016;171.
    PubMed     Text format     Abstract available


    February 2016
  561. GARDSJORD ES, Romm KL, Friis S, Barder HE, et al
    Subjective quality of life in first-episode psychosis. A ten year follow-up study.
    Schizophr Res. 2016 Feb 29. pii: S0920-9964(16)30087.
    PubMed     Text format     Abstract available


  562. MALASPINA D, Kranz TM, Heguy A, Harroch S, et al
    Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30085.
    PubMed     Text format     Abstract available


  563. BRANDT AS, Unschuld PG, Pradhan S, Lim IA, et al
    Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A H MRS Study at 7Tesla.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30073.
    PubMed     Text format     Abstract available


  564. MOE AM, Breitborde NJ, Shakeel MK, Gallagher CJ, et al
    Idea density in the life-stories of people with schizophrenia: Associations with narrative qualities and psychiatric symptoms.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30072.
    PubMed     Text format     Abstract available


  565. SALGADO-PINEDA P, Landin-Romero R, Portillo F, Bosque C, et al
    Examining hippocampal function in schizophrenia using a virtual reality spatial navigation task.
    Schizophr Res. 2016 Feb 25. pii: S0920-9964(16)30089.
    PubMed     Text format     Abstract available


  566. FRAJO-APOR B, Pardeller S, Kemmler G, Welte AS, et al
    Emotional Intelligence deficits in schizophrenia: The impact of non-social cognition.
    Schizophr Res. 2016 Feb 25. pii: S0920-9964(16)30082.
    PubMed     Text format     Abstract available


  567. STEINER J, Brisch R, Schiltz K, Dobrowolny H, et al
    GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study.
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30074.
    PubMed     Text format     Abstract available


  568. LITMAN RE, Smith MA, Doherty JJ, Cross A, et al
    AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30057.
    PubMed     Text format     Abstract available


  569. LANDOLT K, Rossler W, Ajdacic-Gross V, Derks EM, et al
    Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30046.
    PubMed     Text format     Abstract available


  570. MOSKOW DM, Addington J, Bearden CE, Cadenhead KS, et al
    The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis.
    Schizophr Res. 2016 Feb 20. pii: S0920-9964(16)30058.
    PubMed     Text format     Abstract available


  571. BATTY RA, Francis A, Thomas N, Hopwood M, et al
    Predicting co-morbid traumatic brain injury and psychosis from neuropsychological profile.
    Schizophr Res. 2016 Feb 19. pii: S0920-9964(16)30076.
    PubMed     Text format    


  572. BUCHY L, Barbato M, MacMaster FP, Bray S, et al
    Cognitive insight is associated with cortical thickness in first-episode psychosis.
    Schizophr Res. 2016 Feb 18. pii: S0920-9964(16)30081.
    PubMed     Text format     Abstract available


  573. XIAO X, Li M
    Replication of Han Chinese GWAS loci for schizophrenia via meta-analysis of four independent samples.
    Schizophr Res. 2016 Feb 18. pii: S0920-9964(16)30075.
    PubMed     Text format     Abstract available


  574. ALLSWEDE DM, Buka SL, Yolken RH, Torrey EF, et al
    Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring.
    Schizophr Res. 2016 Feb 17. pii: S0920-9964(16)30077.
    PubMed     Text format     Abstract available


  575. FORERO DA, Herteleer L, De Zutter S, Norrback KF, et al
    A network of synaptic genes associated with schizophrenia and bipolar disorder.
    Schizophr Res. 2016 Feb 15. pii: S0920-9964(16)30068.
    PubMed     Text format     Abstract available


  576. NIELSEN PR, Meyer U, Mortensen PB
    Individual and combined effects of maternal anemia and prenatal infection on risk for schizophrenia in offspring.
    Schizophr Res. 2016 Feb 15. pii: S0920-9964(16)30080.
    PubMed     Text format     Abstract available


  577. DAGANI J, Sisti D, Abelli M, Di Paolo L, et al
    Do we need oxytocin to treat schizophrenia? A randomized clinical trial.
    Schizophr Res. 2016 Feb 13. pii: S0920-9964(16)30067.
    PubMed     Text format     Abstract available


  578. DARRELL-BERRY H, Berry K, Bucci S
    The relationship between paranoia and aggression in psychosis: A systematic review.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30065.
    PubMed     Text format     Abstract available


  579. LEE MR, Wehring HJ, McMahon RP, Liu F, et al
    Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30070.
    PubMed     Text format     Abstract available


  580. OAKLEY C, Harris S, Fahy T, Murphy D, et al
    Childhood adversity and conduct disorder: A developmental pathway to violence in schizophrenia.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30047.
    PubMed     Text format     Abstract available


  581. PIERRE JM, Gandal M, Son M
    Cannabis-induced psychosis associated with high potency "wax dabs".
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30056.
    PubMed     Text format     Abstract available


  582. KNOCHEL C, Reuter J, Reinke B, Stablein M, et al
    Cortical thinning in bipolar disorder and schizophrenia.
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30063.
    PubMed     Text format     Abstract available


  583. PINNER AL, Tucholski J, Haroutunian V, McCullumsmith RE, et al
    Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30055.
    PubMed     Text format     Abstract available


  584. ROMERO-FERREIRO MV, Aguado L, Rodriguez-Torresano J, Palomo T, et al
    Facial affect recognition in early and late-stage schizophrenia patients.
    Schizophr Res. 2016 Feb 10. pii: S0920-9964(16)30066.
    PubMed     Text format     Abstract available


  585. IWASHIRO N, Koike S, Satomura Y, Suga M, et al
    Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: A multi-modal neuroimaging study.
    Schizophr Res. 2016 Feb 9. pii: S0920-9964(16)30061.
    PubMed     Text format     Abstract available


  586. PERES FF, Diana MC, Suiama MA, Justi V, et al
    Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30060.
    PubMed     Text format    


  587. CAO B, Wang DF, Xu MY, Liu YQ, et al
    Vitamin B and the risk of schizophrenia: A meta-analysis.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30051.
    PubMed     Text format    


  588. KOCAZEYBEK B, Yuksel P
    A contribution to the Torrey et al.'s "cat ownership in childhood is a significant risk factor for later developing schizophrenia" study.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30052.
    PubMed     Text format    


  589. NIENOW TM, MacDonald AW 3rd, Lim KO
    TDCS produces incremental gain when combined with working memory training in patients with schizophrenia: A proof of concept pilot study.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30053.
    PubMed     Text format    


  590. VENTURA J, Subotnik KL, Ered A, Hellemann GS, et al
    Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30030.
    PubMed     Text format     Abstract available


  591. ZENG B, Ardekani BA, Tang Y, Zhang T, et al
    Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Schizophr Res. 2016 Feb 3. pii: S0920-9964(16)30050.
    PubMed     Text format     Abstract available


  592. KIMHY D, Lauriola V, Bartels MN, Armstrong HF, et al
    Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Schizophr Res. 2016 Feb 3. pii: S0920-9964(16)30054.
    PubMed     Text format    


  593. TARASENKO M, Perez VB, Pianka ST, Vinogradov S, et al
    Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia.
    Schizophr Res. 2016 Feb 2. pii: S0920-9964(16)30017.
    PubMed     Text format     Abstract available


  594. GADELHA A, Coleman J, Breen G, Mazzoti DR, et al
    Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity.
    Schizophr Res. 2016 Feb 2. pii: S0920-9964(16)30043.
    PubMed     Text format     Abstract available


  595. XU Z, Muller M, Heekeren K, Theodoridou A, et al
    Pathways between stigma and suicidal ideation among people at risk of psychosis.
    Schizophr Res. 2016 Feb 1. pii: S0920-9964(16)30048.
    PubMed     Text format     Abstract available


  596. LODHI RJ, Masand S, Malik A, Shivakumar K, et al
    Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study.
    Schizophr Res. 2016;170.
    PubMed     Text format     Abstract available


    January 2016
  597. PU S, Nakagome K, Itakura M, Iwata M, et al
    The association between cognitive deficits and prefrontal hemodynamic responses during performance of working memory task in patients with schizophrenia.
    Schizophr Res. 2016 Jan 30. pii: S0920-9964(16)30045.
    PubMed     Text format     Abstract available


  598. LALANDE D, Theriault L, Kalinova E, Fortin A, et al
    The effect of exercise on sleep quality and psychological, physiological, and biological correlates in patients with schizophrenia: A pilot study.
    Schizophr Res. 2016 Jan 28. pii: S0920-9964(16)30041.
    PubMed     Text format    


  599. KNOCHEL C, Stablein M, Prvulovic D, Ghinea D, et al
    Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment.
    Schizophr Res. 2016 Jan 28. pii: S0920-9964(16)30025.
    PubMed     Text format     Abstract available


  600. KARPOUZIAN TM, Alden EC, Reilly JL, Smith MJ, et al
    High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30031.
    PubMed     Text format     Abstract available


  601. LALLY J, Tully J, Robertson D, Stubbs B, et al
    Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30024.
    PubMed     Text format     Abstract available


  602. FULLARD JF, Halene TB, Giambartolomei C, Haroutunian V, et al
    Understanding the genetic liability to schizophrenia through the neuroepigenome.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30039.
    PubMed     Text format     Abstract available


  603. BUCCI P, Mucci A, Piegari G, Nobile M, et al
    Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings.
    Schizophr Res. 2016 Jan 26. pii: S0920-9964(16)30035.
    PubMed     Text format     Abstract available


  604. BI R, Tang J, Zhang W, Li X, et al
    Mitochondrial genome variations and functional characterization in Han Chinese families with schizophrenia.
    Schizophr Res. 2016 Jan 25. pii: S0920-9964(16)30011.
    PubMed     Text format     Abstract available


  605. HO RT, Fong TC, Wan AH, Au-Yeung FS, et al
    A randomized controlled trial on the psychophysiological effects of physical exercise and Tai-chi in patients with chronic schizophrenia.
    Schizophr Res. 2016 Jan 25. pii: S0920-9964(16)30038.
    PubMed     Text format     Abstract available


  606. BLIKSTED V, Ubukata S, Koelkebeck K
    Discriminating autism spectrum disorders from schizophrenia by investigation of mental state attribution on an on-line mentalizing task: A review and meta-analysis.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30028.
    PubMed     Text format     Abstract available


  607. VUKADINOVIC Z
    Elevated striatal dopamine and efference copy failure in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30040.
    PubMed     Text format    


  608. CSUKLY G, Farkas K, Marosi C, Szabo A, et al
    Deficits in low beta desynchronization reflect impaired emotional processing in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30029.
    PubMed     Text format     Abstract available


  609. BURTON CZ, Harvey PD, Patterson TL, Twamley EW, et al
    Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30022.
    PubMed     Text format     Abstract available


  610. SUGAI T, Suzuki Y, Yamazaki M, Shimoda K, et al
    Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey.
    Schizophr Res. 2016 Jan 22. pii: S0920-9964(16)30016.
    PubMed     Text format     Abstract available


  611. LENG CH, Chou MH, Lin SH, Yang YK, et al
    Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Schizophr Res. 2016 Jan 22. pii: S0920-9964(16)30036.
    PubMed     Text format     Abstract available


  612. STUBBS B, Williams J, Gaughran F, Craig T, et al
    How sedentary are people with psychosis? A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30037.
    PubMed     Text format     Abstract available


  613. HOFER A, Mizuno Y, Frajo-Apor B, Kemmler G, et al
    Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30034.
    PubMed     Text format     Abstract available


  614. LABAD J, Barbero JD, Gutierrez-Zotes A, Montalvo I, et al
    Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: A prospective 1-year follow-up study.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30026.
    PubMed     Text format     Abstract available


  615. LIU C, Xue Z, Palaniyappan L, Zhou L, et al
    Abnormally increased and incoherent resting-state activity is shared between patients with schizophrenia and their unaffected siblings.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30021.
    PubMed     Text format     Abstract available


  616. YOSHIDA K, Suzuki T, Imasaka Y, Kubo KI, et al
    Resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30033.
    PubMed     Text format     Abstract available


  617. TONNA M, Ottoni R, Paglia F, Ossola P, et al
    Obsessive-compulsive symptoms interact with disorganization in influencing social functioning in schizophrenia.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30001.
    PubMed     Text format     Abstract available


  618. PARIKH V, Kutlu MG, Gould TJ
    nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30018.
    PubMed     Text format     Abstract available


  619. TREEN D, Batlle S, Molla L, Forcadell E, et al
    Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30002.
    PubMed     Text format     Abstract available


  620. KOH MT, Shao Y, Sherwood A, Smith DR, et al
    Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.
    Schizophr Res. 2016 Jan 19. pii: S0920-9964(16)30023.
    PubMed     Text format     Abstract available


  621. SUN Y, Chen Y, Lee R, Bezerianos A, et al
    Disruption of brain anatomical networks in schizophrenia: A longitudinal, diffusion tensor imaging based study.
    Schizophr Res. 2016 Jan 19. pii: S0920-9964(16)30027.
    PubMed     Text format     Abstract available


  622. BRIDGMAN AC, Barr MS, Goodman MS, Chen R, et al
    Deficits in GABA receptor function and working memory in non-smokers with schizophrenia.
    Schizophr Res. 2016 Jan 18. pii: S0920-9964(16)30008.
    PubMed     Text format     Abstract available


  623. HAMAZAKI K, Maekawa M, Toyota T, Iwayama Y, et al
    Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study.
    Schizophr Res. 2016 Jan 17. pii: S0920-9964(16)30014.
    PubMed     Text format     Abstract available


  624. PISKULIC D, Liu L, Cadenhead KS, Cannon TD, et al
    Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Schizophr Res. 2016 Jan 16. pii: S0920-9964(16)30020.
    PubMed     Text format     Abstract available


  625. KELLEY ME, Wan CR, Broussard B, Crisafio A, et al
    Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Schizophr Res. 2016 Jan 16. pii: S0920-9964(16)30015.
    PubMed     Text format     Abstract available


  626. EKSTROM T, Maher S, Shinn A, Ongur D, et al
    Face identity discrimination in schizophrenia: Impairments to faces with high exposure in society.
    Schizophr Res. 2016 Jan 15. pii: S0920-9964(16)30009.
    PubMed     Text format    


  627. ALESSANDRINI M, Lancon C, Fond G, Faget-Agius C, et al
    A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.
    Schizophr Res. 2016 Jan 15. pii: S0920-9964(16)30010.
    PubMed     Text format     Abstract available


  628. PENADES R, Pujol N, Catalan R, Masana G, et al
    Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophrenia.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(16)30004.
    PubMed     Text format     Abstract available


  629. WILSON C, Smith ME, Thompson E, Demro C, et al
    Context matters: The impact of neighborhood crime and paranoid symptoms on psychosis risk assessment.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(16)30007.
    PubMed     Text format     Abstract available


  630. YAKOVENKO I, Clark CM, Hodgins DC, Goghari VM, et al
    A qualitative analysis of the effects of a comorbid disordered gambling diagnosis with schizophrenia.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(15)30081.
    PubMed     Text format     Abstract available


  631. YAMANAKA H, Kanahara N, Suzuki T, Takase M, et al
    Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.
    Schizophr Res. 2016 Jan 13. pii: S0920-9964(16)30013.
    PubMed     Text format     Abstract available


  632. CARNEY R, Cotter J, Bradshaw T, Firth J, et al
    Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 12. pii: S0920-9964(16)30012.
    PubMed     Text format     Abstract available


  633. KOIKE S, Satomura Y, Kawasaki S, Nishimura Y, et al
    Association between rostral prefrontal cortical activity and functional outcome in first-episode psychosis: a longitudinal functional near-infrared spectroscopy study.
    Schizophr Res. 2016 Jan 11. pii: S0920-9964(16)30006.
    PubMed     Text format     Abstract available


  634. VANCAMPFORT D, Stubbs B, Probst M, De Hert M, et al
    Physical activity as a vital sign in patients with schizophrenia: Evidence and clinical recommendations.
    Schizophr Res. 2016 Jan 9. pii: S0920-9964(16)30005.
    PubMed     Text format     Abstract available


  635. CHANG WC, Hui CL, Chan SK, Lee EH, et al
    Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study.
    Schizophr Res. 2016 Jan 9. pii: S0920-9964(16)30003.
    PubMed     Text format     Abstract available


  636. HETTIGE NC, Cole CB, Khalid S, De Luca V, et al
    Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
    Schizophr Res. 2016 Jan 8. pii: S0920-9964(15)30087.
    PubMed     Text format     Abstract available


  637. MCCARTHY JM, Treadway MT, Bennett ME, Blanchard JJ, et al
    Inefficient effort allocation and negative symptoms in individuals with schizophrenia.
    Schizophr Res. 2016 Jan 4. pii: S0920-9964(15)30090.
    PubMed     Text format     Abstract available


  638. HOCHBERGER WC, Hill SK, Nelson CL, Reilly JL, et al
    Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.
    Schizophr Res. 2016;170:156-61.
    PubMed     Text format     Abstract available


    December 2015
  639. JAHN DR, Bennett ME, Park SG, Gur RE, et al
    The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia.
    Schizophr Res. 2015 Dec 30. pii: S0920-9964(15)30084.
    PubMed     Text format     Abstract available


  640. STRAUSS GP, Vertinski M, Vogel SJ, Ringdahl EN, et al
    Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Schizophr Res. 2015 Dec 29. pii: S0920-9964(15)30088.
    PubMed     Text format     Abstract available


  641. ALPHS L, Mao L, Lynn Starr H, Benson C, et al
    A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia.
    Schizophr Res. 2015 Dec 29. pii: S0920-9964(15)30085.
    PubMed     Text format     Abstract available


  642. TSOUTSOULAS C, Mulsant BH, Kalache SM, Kumar S, et al
    The influence of medical burden severity and cognition on functional competence in older community-dwelling individuals with schizophrenia.
    Schizophr Res. 2015 Dec 24. pii: S0920-9964(15)30082.
    PubMed     Text format     Abstract available


  643. COLIZZI M, Carra E, Fraietta S, Lally J, et al
    Substance use, medication adherence and outcome one year following a first episode of psychosis.
    Schizophr Res. 2015 Dec 21. pii: S0920-9964(15)30058.
    PubMed     Text format     Abstract available


  644. REID MA, White DM, Kraguljac NV, Lahti AC, et al
    A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Schizophr Res. 2015 Dec 21. pii: S0920-9964(15)30076.
    PubMed     Text format     Abstract available


  645. COHEN AS, Callaway DA, Mitchell KR, Larsen JT, et al
    A temporal examination of co-activated emotion valence networks in schizophrenia and schizotypy.
    Schizophr Res. 2015 Dec 19. pii: S0920-9964(15)30083.
    PubMed     Text format     Abstract available


  646. LIU T, Zheng X
    Cultural revolution and onset of schizophrenia in China.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30059.
    PubMed     Text format    


  647. PAKSARIAN D, Merikangas KR, Calkins ME, Gur RE, et al
    Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a U.S. sample of youths.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30077.
    PubMed     Text format     Abstract available


  648. NANDA P, Tandon N, Mathew IT, Padmanabhan JL, et al
    Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30073.
    PubMed     Text format     Abstract available


  649. SHIM S, Shuman M, Duncan E
    An emerging role of cGMP in the treatment of schizophrenia: A review.
    Schizophr Res. 2015 Dec 16. pii: S0920-9964(15)30057.
    PubMed     Text format     Abstract available


  650. STRAUSS GP, Whearty KM, Morra LF, Sullivan SK, et al
    Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task.
    Schizophr Res. 2015 Dec 14. pii: S0920-9964(15)30079.
    PubMed     Text format     Abstract available


  651. MAHER S, Mashhoon Y, Ekstrom T, Lukas S, et al
    Deficient cortical face-sensitive N170 responses and basic visual processing in schizophrenia.
    Schizophr Res. 2015 Dec 12. pii: S0920-9964(15)30078.
    PubMed     Text format     Abstract available


  652. LIZANO PL, Keshavan MS, Tandon N, Mathew IT, et al
    Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.
    Schizophr Res. 2015 Dec 11. pii: S0920-9964(15)30074.
    PubMed     Text format     Abstract available


  653. LYSTAD JU, Falkum E, Haaland VO, Bull H, et al
    Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
    Schizophr Res. 2015 Dec 11. pii: S0920-9964(15)30075.
    PubMed     Text format     Abstract available


  654. HELLE S, Ringen PA, Melle I, Larsen TK, et al
    Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Schizophr Res. 2015 Dec 9. pii: S0920-9964(15)30070.
    PubMed     Text format     Abstract available


  655. WANG X, Yu X, Appelbaum PS, Tang H, et al
    Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up study.
    Schizophr Res. 2015 Dec 8. pii: S0920-9964(15)30062.
    PubMed     Text format     Abstract available


  656. CHI MH, Hsiao CY, Chen KC, Lee LT, et al
    The readmission rate and medical cost of patients with schizophrenia after first hospitalization - A 10-year follow-up population-based study.
    Schizophr Res. 2015 Dec 8. pii: S0920-9964(15)30068.
    PubMed     Text format     Abstract available


  657. ENGEL M, Fritzsche A, Lincoln TM
    Anticipation and experience of emotions in patients with schizophrenia and negative symptoms. An experimental study in a social context.
    Schizophr Res. 2015 Dec 7. pii: S0920-9964(15)30071.
    PubMed     Text format     Abstract available


  658. SHASTEEN JR, Pinkham AE, Kelsven S, Ludwig K, et al
    Intact implicit processing of facial threat cues in schizophrenia.
    Schizophr Res. 2015 Dec 7. pii: S0920-9964(15)30072.
    PubMed     Text format     Abstract available


  659. DU Y, Pearlson GD, Yu Q, He H, et al
    Interaction among subsystems within default mode network diminished in schizophrenia patients: A dynamic connectivity approach.
    Schizophr Res. 2015 Dec 3. pii: S0920-9964(15)30064.
    PubMed     Text format     Abstract available


    November 2015
  660. RAMAGE EM, Klimas N, Vogel SJ, Vertinski M, et al
    Concurrent sound segregation impairments in schizophrenia: The contribution of auditory-specific and general cognitive factors.
    Schizophr Res. 2015 Nov 28. pii: S0920-9964(15)30066.
    PubMed     Text format     Abstract available


  661. LIN A, Wardenaar KJ, Pontillo M, De Crescenzo F, et al
    Is it still correct to differentiate between early and very early onset psychosis?
    Schizophr Res. 2015 Nov 27. pii: S0920-9964(15)30063.
    PubMed     Text format     Abstract available


  662. VINK M, de Leeuw M, Pouwels R, van den Munkhof HE, et al
    Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients.
    Schizophr Res. 2015 Nov 26. pii: S0920-9964(15)30061.
    PubMed     Text format     Abstract available


  663. MYLES H, Myles N, Antic NA, Adams R, et al
    Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30060.
    PubMed     Text format     Abstract available


  664. MALAN-MULLER S, Kilian S, van den Heuvel LL, Bardien S, et al
    A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30054.
    PubMed     Text format     Abstract available


  665. BRENT BK, Rosso IM, Thermenos HW, Holt DJ, et al
    Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30056.
    PubMed     Text format     Abstract available


  666. WATANUKI T, Matsuo K, Egashira K, Nakashima M, et al
    Precentral and inferior prefrontal hypoactivation during facial emotion recognition in patients with schizophrenia: A functional near-infrared spectroscopy study.
    Schizophr Res. 2015 Nov 20. pii: S0920-9964(15)30055.
    PubMed     Text format     Abstract available


  667. DICKERSON F, Origoni A, Schroeder J, Schweinfurth LA, et al
    Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors.
    Schizophr Res. 2015 Nov 19. pii: S0920-9964(15)30053.
    PubMed     Text format     Abstract available


  668. GAEBEL W, Riesbeck M, Wolwer W, Klimke A, et al
    Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.
    Schizophr Res. 2015 Nov 19. pii: S0920-9964(15)30024.
    PubMed     Text format     Abstract available


  669. ZHANG XY, Chen DC, Tan YL, Tan SP, et al
    BDNF polymorphisms are associated with schizophrenia onset and positive symptoms.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30052.
    PubMed     Text format     Abstract available


  670. EMAMI S, Guimond S, Mallar Chakravarty M, Lepage M, et al
    Cortical thickness and low insight into symptoms in enduring schizophrenia.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30016.
    PubMed     Text format     Abstract available


  671. VANMEERTEN NJ, Dubke RE, Stanwyck JJ, Kang SS, et al
    Abnormal early brain responses during visual search are evident in schizophrenia but not bipolar affective disorder.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30050.
    PubMed     Text format     Abstract available


  672. GREENWOOD TA, Lazzeroni LC, Calkins ME, Freedman R, et al
    Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.
    Schizophr Res. 2015 Nov 17. pii: S0920-9964(15)30051.
    PubMed     Text format     Abstract available


  673. BREITBORDE NJ, Dawley D, Bell EK, Vanuk JR, et al
    A personalized paced-breathing intervention to increase heart rate variability among individuals with first-episode psychosis following stress exposure.
    Schizophr Res. 2015 Nov 16. pii: S0920-9964(15)30048.
    PubMed     Text format    


  674. BERNA F, Misdrahi D, Boyer L, Aouizerate B, et al
    Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
    Schizophr Res. 2015 Nov 15. pii: S0920-9964(15)30040.
    PubMed     Text format     Abstract available


  675. FAN N, Luo Y, Xu K, Zhang M, et al
    Relationship of serum levels of TNF-alpha, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30049.
    PubMed     Text format     Abstract available


  676. KEINANEN J, Mantere O, Kieseppa T, Mantyla T, et al
    Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis - A one year follow-up study.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30045.
    PubMed     Text format    


  677. KOGA M, Serritella AV, Sawa A, Sedlak TW, et al
    Implications for reactive oxygen species in schizophrenia pathogenesis.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)00337.
    PubMed     Text format     Abstract available


  678. LYNGBERG K, Buchy L, Liu L, Perkins D, et al
    Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30047.
    PubMed     Text format     Abstract available


  679. HEALD A, Sein K, Anderson S, Pendlebury J, et al
    Diet, exercise and the metabolic syndrome in schizophrenia: A cross-sectional study.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30043.
    PubMed     Text format    


  680. MAUNEY SA, Pietersen CY, Sonntag KC, Woo TW, et al
    Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30042.
    PubMed     Text format     Abstract available


  681. SCHAEFFER DJ, Rodrigue AL, Burton CR, Pierce JE, et al
    White matter structural integrity differs between people with schizophrenia and healthy groups as a function of cognitive control.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30044.
    PubMed     Text format     Abstract available


  682. MUNOZ-NEGRO JE, Ibanez-Casas I, de Portugal E, Ochoa S, et al
    A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30039.
    PubMed     Text format    


  683. KRAAN T, van Dam DS, Velthorst E, de Ruigh EL, et al
    Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30026.
    PubMed     Text format    


    October 2015
  684. BEHDINAN T, Foussias G, Wheeler AL, Stefanik L, et al
    Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)30023.
    PubMed     Text format     Abstract available


  685. SASS LA, Borda JP
    Phenomenology and neurobiology of self disorder in schizophrenia: Secondary factors.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)00520.
    PubMed     Text format    


  686. MAMAH D, Wen J, Luo J, Ulrich X, et al
    Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)30004.
    PubMed     Text format     Abstract available


    July 2015
  687. NICOTRA E, Casu G, Piras S, Marchese G, et al
    On the use of the Positive and Negative Syndrome Scale in randomized clinical trials.
    Schizophr Res. 2015;165.
    PubMed     Text format     Abstract available


    May 2015
  688. RAMANATHAN S, Miewald J, Montrose D, Keshavan MS, et al
    Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?
    Schizophr Res. 2015;164.
    PubMed     Text format     Abstract available


    March 2015
  689. SUN Y, Hu D, Liang J, Bao YP, et al
    Association between variants of zinc finger genes and psychiatric disorders: systematic review and meta-analysis.
    Schizophr Res. 2015;162.
    PubMed     Text format     Abstract available


  690. TAKAGI S, Balu DT, Coyle JT
    Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Schizophr Res. 2015;162.
    PubMed     Text format     Abstract available


    February 2015
  691. JOHNSON KL, Desmarais SL, Swartz MS, Van Dorn RA, et al
    Latent class analysis of discordance between results of drug use assessments in the CATIE data.
    Schizophr Res. 2015;161.
    PubMed     Text format     Abstract available


  692. BASKAK B, Baran Z, Ozguven HD, Karaboga I, et al
    Prefrontal activity measured by functional near infrared spectroscopy during probabilistic inference in subjects with persecutory delusions.
    Schizophr Res. 2015;161.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: